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ABSTRACT 
 During development, cells receive many cues from their environment. These cues, 
whether physical or chemical in nature, are able to regulate the behavior of cells from 
macroscale levels such as tissue organization, to microscale levels such as gene modifications. 
Synthetic materials are able to similarly affect cell phenotype, and recent advances in 
microarray technology has allowed the systematic investigation of a large combinatorial space 
of material properties. As we gain new insights on the effects of chemical structures and 
physical properties, controlling the interaction between these various components at the cell-
material interface will be invaluable in developing new materials for biomedical devices and 
tissue engineering applications.  
 The aim of this project is to develop a peptide array to screen for specific cell-ligand 
interactions. We synthesize a library of peptides that are derived from extracellular matrix 
proteins and serve as a highly scalable synthetic microenvironment. We demonstrate that by 
displaying combinations of peptides on the surface of self-assembled monolayers, we can affect 
stem and cancer stem cell fate. In chapter 2 we demonstrate that self-assembled monolayers 
provide a facile method for modulating cell phenotype. In chapter 3 we incorporate peptide 
ligands at the cell-monolayer interface and show that ligand affinity can regulate differentiation. 
In chapters 4 and 5 we present a high-throughput array platform that allows combinatorial 
investigation of a library of biomimetic peptides. We report that the array platform is capable of 
screening for cancer stem cell phenotypic changes in response to the underlying substrate. We 
are able to identify a specific combination of peptides that selectively enhance the expression of 
several putative melanoma cancer stem cell markers and enhance invasiveness and 
tumorigenicty. Such a platform will be useful as in vitro drug screening models to identify 
therapeutic targets.     
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CHAPTER 1 
INTRODUCTION 
1.1 The role of the extracellular matrix within the cellular microenvironment 
During natural development, cells are exposed to a complex milieu of biophysical and 
biochemical cues which collectively constitute the cellular microenvironment or niche. Ultimately 
these signals, which include cell-cell interactions and physical-chemical interactions between 
extracellular matrix (ECM) and soluble factors, are able to organize single cells into the complex 
and diverse tissues necessary to sustain life. A major challenge in studying these cell-material 
interactions lies in the enormous complexity of the components. For instance, a single ECM 
protein may have multiple binding domains and configurations, each buried or exposed 
depending on the local biochemical environment[1]. 
Furthermore, the ECM is composed of hundreds of large complex proteins. These various 
proteins not only serve as independent signal transducers, but can also harbor and establish 
chemotactic gradients of growth factors[2] as well as provide “cross-talk” signaling between 
ECM protein and soluble growth factors[3]. 
ECM proteins can be divided into major classes:  
(1) Structural proteins such as collagens and elastins.  Collagens are fibrillar chains of 
polypeptides (over 20 types are known to be present in the human body) that serve as 
the primary structural support in the human body[4].  Elastins are the other major 
structural protein in the ECM, and along with fibrillin, is responsible for the flexibility of 
many tissues. [5,6] 
(2) Multidomain adhesive glycoproteins such as fibronectin, vitronectin, and laminin, which 
bind to many other ECM components such as proteins, growth factors, signal receptors, 
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and adhesion molecules[5,6].  One of the most well studied, fibronectin (FN), is known to 
contain binding sites in its FNIII domain for the RGD amino acid sequence[7]. 
(3) Glycosaminoglycans (GAGs) such as hyaluronan, and proteoglycans (PGs), which can 
often contain GAG side chains (ex: heparan sulphate proteoglycans (HSPGs)) serve to 
bind almost all the structural proteins in the ECM[6] as well as also acting as potential 
reservoirs for growth factors and cytokines[8]. 
Cellular interaction with the various ECM proteins occurs primarily through integrins.  Integrins 
are a large family of heterodimeric glycoproteins consisting of an α and β subunit.  These units 
are non-covalently linked transmembrane proteins with large extracellular domains.  18 α and 8 
β subunits have been discovered, though only 24 different α-β combinations are known[9].  
Integrins play a key role in cellular adhesion as well as regulating cytoskeletal organization and 
transmembrane signal transduction[10].  When ECM molecules bind to their specific integrin 
receptors, a change in the cytoplasmic domain of the receptor occurs[11].  These changes are 
associated with integrin clustering and focal adhesion formation[12].  Focal adhesion formation 
is mediated by a variety of proteins including talin, vinculin, and paxilin[6,12,13].  Integrin 
binding modulates the actin cytoskeleton, which can in turn mediate major signal transduction 
pathways, leading to changes in cell shape, motility, proliferation, and differentiation (Figure 
1.1)[13,14].   
ECM can also regulate cellular function through the binding of growth factors by charged GAG 
side chains.  For example, HSPGs have been shown to augment fibroblast growth factor 
(FGF)/fibroblast growth factor receptor (FGFR) binding and promote FGFR dimerization[15]. 
Using plasmon resonance to measure binding constants of FGF to the FGF receptor in the 
presence and absence of heparin, Ibrahimi et al. concluded that HSPGs both influences the 
thermodynamics of receptor/growth factor  interactions by stabilizing the ternary complexes 
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required for binding, and also improves the kinetics by concentrating growth factor and limiting 
the diffusion of soluble factors[15].   
Integrins can thus activate cell signaling pathways independently, but often they act 
synergistically with other growth factor receptors[3].  The ability of heparin to bind to many 
different classes of proteins ranging from growth factors (FGFs, VEGFs, PDGF, etc.) to 
cytokines, to metabolic enzymes and other structural proteins[6] suggests the importance of 
proteoglycans in signal regulation as well. These interactions between ECM proteins and growth 
factors thus promote distinct cellular niches that can regulate cell fate and behavior[11]. 
1.2 Microarray platforms for studying cell-material interactions 
In order to analyze such a complicated system, many groups have developed medium to high-
throughput screening platforms in which individual components of the ECM can be investigated 
in parallel. These microarray screening platforms are typically conducted on a 2D substrate 
(most commonly 25mm x 75mm glass slides) and can contain hundreds to thousands of unique 
spots, each representative of a synthetic microenvironment. This strategy allows simultaneous 
analysis and parallelization of large combinations of biomolecules common to the ECM, allowing 
investigators to parallel some of the complexities of the in vivo niche.  
Microarray technology provides the flexibility of choosing many different biomolecules for 
recreating a synthetic niche. However, materials to model ECM must incorporate several design 
elements. They should be well defined in terms of ligand identity, presentation, and density[16], 
and present an inert background to prevent nonspecific adsorption. In this section we highlight 
important considerations in the preparation of microarrays as well as key advances and insights 
gleaned from various array platforms.     
Substrate and printing method 
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Most microarray techniques employ traditional glass slides as the substrate and then further 
modify the surface to suit a specific chemistry (e.g., glass surface for silane-based chemistry or 
gold surface for thiol-based chemistry, etc.). Traditional glass slides provide flexibility as many 
downstream processes such as cell culture and imaging support standard 25mm x 75mm 
dimensions. 
The most common printing methods are contact printing, inkjet printing, and photolithography 
(Figure 1.2). In contact printing, typically a robotic handler system dips a small metallic pin into a 
solution, then deposits nanoliters of solution onto a surface by making contact with the 
substrate. This method is preferred for its ease of transfer as well as the small amounts of 
solvents required. Inkjet printing is a non-contact method that allows for multiple drops of 
solution to be deposited at the same location. Monomers and initiators can thus be mixed this 
way to form polymer or hydrogel microarrays[17]. Photolithography approaches involve 
irradiating a substrate with high energy beams (typically UV light) through a photomask to 
initiate polymerization in discreet spots. Similarly, an elastomeric stamp containing set patterns 
can be fabricated using soft lithography and this stamp can be subsequently used to generate a 
patterned surface. Many reviews have been written about methods for generating microarrays 
and their applications[18–21]. The remainder of this section will focus on the specific 
biomolecules that are typically deposited in these microarray platforms and their applications in 
studying cell-ligand interactions and how these interactions affect downstream cellular 
processes 
Polymeric biomaterials 
An early application demonstrating the efficacy of synthetic polymer arrays was described by 
Kohn et al. who prepared a combinatorial library of aromatic polyesters by reacting 14 diphenols 
and 8 diacid monomers to produce 112 distinct polymers. They used this polymer array to study 
fibroblast adhesion and proliferation and found that increased proliferation was correlated with 
5 
 
surface hydrophobicity[22]. Later, a seminal report by Anderson et al. used robotic handling 
technology to deposit pairwise combinations of 24 different acrylate containing monomers with a 
radical initiator onto a poly(hydroxyethyl methacrylate) (pHEMA) coated glass slide. They 
investigated human embryonic stem cell (hESC) growth and differentiation on these various 
polymer spots[23]. Although such synthetic polymers are not “true” biomolecules in the sense 
that these are not naturally occurring within the body, mostly all in vitro cell culture today is 
performed on similar polymers such as polystyrene. Such studies then are instructive in that 
they allow us to analyze proper culture conditions for specific cell types. The same group later 
used a similar strategy to screen for polymer substrates which could maintain the pluripotency 
of hESCs for more than 2 months of culture[24]. By doing so, they demonstrated that a 
chemically defined polymer substrate had similar maintenance properties to the standard of 
using bovine serum albumin or mouse feeder cells, an important advancement for the eventual 
use of hESCs as potential therapeutics. 
Many other groups have employed a similar polymer-based screening approach to identify 
synthetic surfaces that can enhance cell binding and culture compared to traditional tissue 
culture plastic[25]. Zhang et al. reported on a class of thermoresponsive hydrogels that allow 
long term hESC culture in a xeno-free environment[26], Hay et al. describe a urethane and 
acrylate-based microarray for screening polymers that support the attachment of hESC-derived 
hepatocytes as well as long-term ability to retain a hepatic phenotype[27], and Brafman et al. 
identified several polymers that could support the renewal of human pluripotent stem cells[28]. 
Together these reports highlight the utility of an array-based platform for identifying material 
conditions that enhance cell culture and maintenance. However, synthetic polymers themselves 
typically don’t support the adhesion of cells by directly binding to cell-surface receptors. Instead, 
the biological activities of these polymers is thought to be attributed to the presence of chemical 
groups at the polymer’s surface which can adsorb additional ECM proteins[24]. Thus, many 
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investigators have turned to ECM protein-based arrays to study the role of these proteins and 
their specific effects on the downstream signaling within the cell. 
Extracellular matrix proteins 
Compared to the relatively inexpensive monomers of polymer arrays, ECM proteins are 
generally expensive and are mostly derived from animals, thus they provide a greater risk of 
containing contaminants. However, microarray technology offsets much of the cost associated 
with using proteins, as typically only small volumes of liquids (nl to µl scale reactions) are 
required. Studying cell-protein interactions also holds great potential as ECM proteins generally 
form the backbone of the cellular niche and are capable of initiating cellular signaling cascades 
on their own or in combination with other signaling molecules[29]. In 2000, MacBeath and 
Schreiber reported on a method to spot proteins onto chemically modified glass slides using a 
traditional DNA microarray spotter[30]. They demonstrated that a contact printing approach 
dispensing nanoliter volumes of protein samples was capable of creating high resolution arrays 
for studying specific protein-protein interactions in a high-throughput format. Since then, many 
other investigators have used a similar approach to create ECM protein arrays for a variety of 
applications. Flaim et al. examined 32 different combinations of 5 common extracellular matrix 
molecules and used a traditional DNA microarray spotter to print these proteins onto an 
acrylamide-coated glass slide. They cultured rat hepatocytes on this ECM array and found that 
the hepatocytes adhered differentially on the various combinations. They also cultured mouse 
embryonic stem cells on the ECM array and reported that protein combinations containing 
collagen IV helped promote hepatocyte function, while collagen I and fibronectin appeared to 
help differentiate ES cells into a more hepatic phenotype[31].  
Similar studies followed, using combinatorial protein arrays and factorial analysis to discover 
preferential protein conditions for other biological functions. Kuschel et al. used an array 
containing 14 different ECM proteins to demonstrate that protein arrays could be used to 
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generate adhesion profiles for different cell types[32]. Soen et al. mixed extracellular matrix 
proteins with growth factors and adhesion molecules to create a synthetic molecular 
microenvironment array. They examined the effects of these various protein combinations on 
neural differentiation of human neural precursor cells and found that the presence of Wnt and 
Notch co-stimulation favored maintenance of a multipotent state whereas the presence of bone 
morphogenetic protein 4 induced differentiation of the precursor cells[33]. Other groups also 
reported high throughput platforms using mixtures of ECM proteins and growth factors. 
Nakajima et al. observed growth factor synergies with ECM matrices on neural stem cells and 
their ability to differentiate towards a neuronal or glial specification[34], Brafman et al. 
investigated the role of hepatic stellate cell phenotype[35], Jones et al. screened hepatocytes 
for anti-fibrotic and anti-apoptotic effects[36], and Huang et al. examined murine embryonic 
stem cells and their ability to remain pluripotent on combinatorial arrays featuring ECM proteins 
and growth factor morphogens[37]. As array technology becomes more accessible with 
commercially available tools[38], scientists are able to expand screens to include more proteins. 
While proteins are powerful investigative tools, future applications of next-generation 
biomaterials necessitate the use of cheaper xeno-free bio-ligands. Furthermore, deconstructing 
the precise ligand-receptor interactions with cells on complex protein matrices is challenging. 
Biomimetic peptides  
Proteins present several limitations for studying precise ligand-receptor interactions. Adsorbed 
layers of proteins are heterogeneous, and adsorption depends mostly on the choice of 
substrate, making control of protein distribution and orientation essentially impossible[39]. Thus, 
model systems (such as self-assembled monolayers of alkanethiolates on gold) that present 
short bioactive ligands, have been proposed as important mechanistic tools for investigating 
such ligand-receptor interactions. The use of short peptides for surface modification presents 
several advantages over the use of whole proteins.  Peptides are cost-efficient, easy to 
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synthesize and purify, and able to be conjugated in a spatially defined manner[40].  This is 
especially amenable to industrial scale-up and reproducible modification of synthetic materials 
for potential applications in tissue engineering and clinical devices.  In addition, very low 
concentrations of peptides are needed for maximal spreading (~1fmol/cm2)[41]. Studies on 
model surfaces have demonstrated the utility of peptide sequences to promote cell 
spreading[42], cell mobility[43], proliferation[44], and differentiation[45] on peptide-modified 
biomimetic surfaces.  Just as cross-talk between ECM proteins and growth factors can affect 
signaling transduction pathways, so too can the interaction of peptides.  In order to elucidate the 
effects of these peptide ligands in cell fate decisions and functions, investigators have employed 
high-throughput approaches to screening and analysis. 
Laura Kiessling, a pioneer in the field of peptide arrays, has reported multiple applications of 
peptide microarray technology. Kiessling and coworkers demonstrated that self-assembled 
monolayers of peptide-conjugated alkane thiols could be facilely arrayed onto gold surfaces to 
generate well-ordered and chemically-defined spots[46]. They then used this array platform to 
screen for laminin-derived peptides that could maintain hESC pluripotency[47]. Using phage 
display based on the “biopanning and rapid analysis of selective interactive ligands” (BRASIL) 
technique[48], they were able to identify six novel peptides that possessed embryonal 
carcinoma cell binding capabilities as well as supported growth of undifferentiated human 
embryonic stem cells[49]. Recently, the group has also used the peptide array technology to 
identify heparin-binding peptides that can support long term culture of multiple pluripotent cell 
lines[50]. Notably, these peptide reagents were shown to be amenable to translation to cell 
culture plasticware for ease of use in the laboratory and clinical settings. 
Other groups have also demonstrated the utility of peptide arrays. Yousaf and colleagues 
microarrayed a variety of small molecules and investigated ligand density effects on the 
differentiation of mesenchymal stem cells[51]. They were able to quantitatively assess the 
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concentration of ligand at the surface using cyclic voltammetry, and observed that higher 
densities of ligand promoted higher adipogenic differentiation. Koepsel et al. combined BMP-
binding peptides, proteoglycan binding peptides, and integrin binding peptides and examined 
the effects of ligand binding on human mesenchymal stem cell alkaline phosphatase 
production[52]. They noted that when the RGD binding peptide was absent, the proteoglycan 
peptide and BMP peptide seemed to have no significant effect on alkaline phosphatase 
production. This unexpected result highlights the importance of synergistic ligand interactions as 
well as the need to control signaling contexts (i.e. substrate elasticity, ligand density, etc.). 
Recently, Lin et al. arrayed peptides targeting integrins and TGFβ receptors and showed murine 
mammary epithelial cells only displayed markers of epithelial to mesenchymal transition (EMT) 
on combinations of peptides known to stimulate EMT[53].   
Combinatorial arrays modulating physical and chemical cues 
The array systems previously described are able to provide insight on biochemical interactions 
between cells and the underlying substrata. As our understanding of these bio-material 
interactions grow and as the tools to investigate these phenomena become more widely 
available, researchers are able to adopt increasingly advanced platforms to probe both chemical 
and physical cues in parallel. ECM elasticity has been known to be a key determinant for 
downstream cellular signaling within cells[54]. Classical experiments by Engler et al. using 
mesenchymal stem cells demonstrated that differentiation can be determined solely by the 
compliance of the substrate, with cells favoring a stiffness that matches the modulus of their 
natural in vivo niche[55]. Next-generation array platforms have now been reported to allow 
tunability of this additional parameter. Recently, the Lutolf laboratory developed a method using 
robotic spotting on soft hydrogels that could simulate complex microenvironment niches by not 
only altering the combinations of proteins spotted, but also the modular stiffness of the 
underlying substrate[56]. By examining both biochemical and mechanical cues in parallel, they 
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showed that concurrent pathways could be activated for adipogenesis of mesenchymal stem 
cells; biochemical cues from the proteins appear to be more dominant on lower rigidity 
substrates and become less dominant as mechanical cues override the biochemical cues at 
higher rigidity[57]. Other strategies similarly focus on incorporating additional tunability to the 
traditional microarray format, either by incorporating 3D elements[58,59] or cell-cell contacts 
using co-cultures within the microarray[60].     
Yet despite these advances in array-based techniques, it remains an impracticality to screen 
every combination of cell-ligand interaction. As arrays become more complex and include more 
parameters, it also becomes increasingly difficult to deconvolute the role of each effector. In this 
regard, studies to elucidate the fundamental signaling pathways downstream of cell-material 
binding remain a challenge. With rational experimental design and a focus on physiologically 
relevant systems, microarray technology can provide a powerful tool in the design of new 
biomaterials and therapeutics. 
1.3 Hypothesis and thesis structure 
Advances in cell therapies and tissue engineering will require a greater understanding of the 
inductive capabilities of common material properties and thorough characterization of the 
signaling pathways by which material properties are “felt” by the cell and transduced into 
chemical signaling.  Our goal is to develop a high-throughput platform to identify biomaterial 
substrates that guide various cellular processes. 
We hypothesize that cellular processes such as proliferation and differentiation can be 
influenced in vitro by controlling the cell-material interaction via specific substrates.  As 
previously stated in section 1.2, evidence exists to support this hypothesis: 1) stiffness alone 
has been shown to be sufficient in guiding differentiation of adult stem cells into various 
lineages[55], cells restricted to certain shapes favor specific lineages[61,62], and immobilized 
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extracellular matrix (ECM) ligands have been shown to sustain activation of cell surface 
receptors and enhance downstream signaling pathways[6,63]. These previous studies 
demonstrate how various material properties can be tuned to achieve specific cell responses.  
We believe that a dynamic platform that allows independent control of several materials 
properties – including ligand presentation and cell shape – will (i) identify novel substrates for 
controlling cell fate; (ii) allow further investigation into the mechanisms involved; and (iii) provide 
a basis for more efficacious design of biomaterials incorporating multifunctionalities. 
We test this hypothesis throughout this thesis. In chapter 2 we begin by examining the influence 
of cell shape on the multipotency of mesenchymal stem cells. By doing so, we demonstrate that 
outside-in signaling using microengineered substrates serves as an effective tool for modulating 
cell phenotype. We expand on this patterning platform in chapter 3 by developing a new 
technique which allows the incorporation of specific peptide ligands at the cell-material interface, 
which allows us to investigate specific cell-ligand interactions. In chapter 4 we transition to a 
more high-throughput investigation of peptide ligands by developing an array platform that is 
able to combinatorially spot peptide-conjugated self-assembled monolayers on gold substrates. 
In chapter 5 we show the utility of this array platform by identifying specific microenvironments 
that can enhance melanoma tumorigenicty and potentially serve as a method to identify 
therapeutic targets. Finally in chapter 6 we discuss future directions and applications of our 
array technology and incorporation of additional functionalities for the development of new 
biomaterials.  
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1.4 Figures 
 
 
 
 
 
 
 
Figure 1.1 Signaling from the extracellular environment can be felt by the cell through a variety of mechanisms. 
Cell-cell signaling is mediated through adherin junctions. Mechanotransductive cues can occur through binding of 
integrin receptors to ligands on ECM molecules. This in turn forms focal adhesion complexes containing 
specialized proteins which undergo conformational changes to elicit further signaling downstream. At the nuclear 
membrane, the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex transmits the mechanical forces 
carried by the cytoskeleton to the chromatin. External forces can thus be directly translated within the nucleus in 
the form of changes to transcription factor binding, epigenetic changes, and ultimately changes in gene 
expression. More comprehensive details about mechanotransductive signaling are reviewed 
elsewhere[248,249][250]. 
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Figure 1.2 Many techniques have been reported for printing microarrays. Contact based approaches are the 
most common and allow for precise control of printed features. Inkjet or non-contact printing approaches offer 
advantages of allowing multiple solutions to be deposited at each spot, allowing for greater chemical flexibility. 
Photolithographic approaches use aligned masks to generate the spotted array. 
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CHAPTER 2 
THE EFFECT OF MESENCHYMAL STEM CELL SHAPE ON THE MAINTENANCE OF 
MULTIPOTENCY1 
2.1 Introduction 
Mesenchymal stem cells (MSCs) represent a subpopulation of stromal cells derived from bone 
marrow that can be differentiated into numerous cell lineages.  Friedenstein and co-workers 
initially observed spindle-shaped fibroblast-like cells within bone marrow that were able to form 
colonies of fibroblasts (the colony-forming unit-fibroblasts, CFU-F), which could be induced into 
bone cells [64].  These bone marrow stromal cells (BMSCs) were later termed mesenchymal 
stem cells [65]  and since then, MSCs have now been isolated in nearly all tissues and organs 
in the body [66–68].  Efforts to define the MSC phenotype have focused on the expression of 
cell-surface markers; for example, Stro-1 [69], CD105/endoglin [70], integrin α1 [71], and nerve 
growth factor receptor (NGFR) [72], as well as the absence of hematopoietic markers CD45, 
CD34, CD14 or CD11b, CD79a or CD19 and HLA-DR surface molecules [73].  In vitro, MSCs 
are often characterized by their adherence to tissue culture plastic, their expression of key 
markers including CD105/endoglin, CD73, and CD90, and their ability to differentiate into 
osteoblasts, adipocytes, and chondroblasts [73]. 
MSCs have been extensively studied as a potential candidate for various cell and gene therapy 
treatments.  They offer many advantages in that they can be induced into multiple cell types 
[74], they can be acquired relatively easily from autologous sources, and they are easily 
expandable in vitro.  Autologous sources of MSCs capable of differentiating into many 
mesenchymal phenotypes are of great therapeutic potential for tissue engineering and 
 
1This chapter is adapted from the following publication: 
Douglas Zhang and Kristopher A. Kilian, The effect of mesenchymal stem cell shape on the maintenance of multipotency, 
Biomaterials, 2013. 34, 3962-3969. 
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regenerative medicine where these cells are well studied as a basis for cartilage, bone, neural, 
and tissue repair [75–77].  However, one limitation to the use of MSCs in clinical settings is their 
tendency to lose potency for proliferation and differentiation when cultured in vitro.  Donor age, 
plating density, serum composition, as well as passage time have all been implicated in MSC 
senescence [78–80].  Methods to maintain the long term multipotency of these cells would 
thereby significantly enhance their function as reservoir cells for clinical use.   
Recent evidence suggests MSCs are a subset of perivascular cells [81,82], reside around 
sinusoids [83], remain in a quiescent state [84], and maintain a niche for hematopoietic stem 
cells [85–87].  Material platforms to recapitulate this natural niche environment may offer an 
engineering approach to prolong the in vitro lifespan of MSCs while still maintaining their 
multipotency. Funaki and colleagues altered matrix mechanics and demonstrated that MSCs on 
soft 250-Pa gels become quiescent, but can resume proliferation and differentiation with the 
addition of chemical or mechanical stimuli [88].  Dalby and colleagues reported that MSCs could 
be promoted to undergo osteogenic differentiation if cultured on disordered nanostructures, 
while these same cells retained their mesenchymal phenotypes and multipotency when cultured 
on ordered square nanostructures [89,90].  In both studies, mechanotransductive events 
between the cell and its substrate were key to influencing phenotype.   
In this chapter we show that retention of the mesenchymal stem cell phenotype is promoted by 
restricting cell spreading using microcontact printing of self-assembled monolayers on gold.  
Our results demonstrate that when cultured in patterns, MSCs become quiescent and express 
higher levels of stem cell markers.  Even after removal from patterns—either through 
trypsinization of the cells or desorption of the monolayer chemistry—high levels of these 
markers persist and these cells retain the ability to differentiate to osteoblasts and adipocytes.   
2.2  Materials and methods 
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Materials 
Laboratory chemicals and reagents were purchased from Sigma Aldrich unless otherwise noted.  
Tissue culture plastic ware was purchased from Fisher Scientific.  Cell culture media and 
reagents were purchased from Gibco.  Human MSCs and differentiation media were purchased 
from Lonza and produced by Osiris Therapeutics, Inc. These cells were derived from bone 
marrow isolated from the iliac crest of human volunteers.  MSCs were tested for purity by 
Lonza, and were positive for CD105, CD166, CD29, and CD44, negative for CD14, CD34, and 
CD45 by flow cytometry, and had ability to differentiate into osteogenic, chondrogenic, 
adipogenic lineages (http://www.lonza.com).  The use of human MSCs in this work was 
reviewed and approved by the University of Illinois at Urbana-Champaign Biological Safety 
Institutional Review Board. 
Surface preparation 
Surfaces were fabricated by electron beam evaporation of 5nm of Ti followed by 20nm of Au 
onto cleaned glass coverslips.  To create patterned surfaces, polydimethylsiloxane (PDMS, 
Polysciences, Inc.) stamps were fabricated by polymerization upon a patterned master of 
photoresist (SU-8, MicroChem) created using UV photolithography through a laser printed 
mask.  Stamps featuring circular patterns of 1000µm2 were used.  Stamps were inked with 
10mM octadecanethiol in ethanol, dried under air, and applied to the surface.  Surfaces were 
then incubated overnight with 3mM tri(ethylene glycol) undecanethiol in ethanol to prevent 
protein adsorption and cell adhesion to non-patterned regions.  Next, 50µg/mL fibronectin was 
applied to surface for 1h at room temperature.  For non-patterned surfaces, 50µg/mL fibronectin 
was applied to gold coverslips for 1h.  Surfaces were rinsed with PBS and stored in PBS until 
use. 
Cell source and culture 
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Human mesenchymal stem cells (MSCs) were thawed from cryopreservation (10% DMSO) and 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) low glucose (1g/mL) media 
supplemented with 10% fetal bovine serum (MSC approved FBS; Invitrogen), 1% 
penicillin/streptomycin (p/s), media changed every 3-4 days and passaged at ~80% confluency 
using Trypsin:EDTA (Gibco). Passage 4-8 MSCs were seeded on patterned and non-patterned 
surfaces at a cell density ~5000 cells/cm2.  Patterned surfaces were visually inspected to ensure 
cells were only localized to small circular islands.  Non-patterned surfaces contained cells 
spread in a random arrangement. 
Cell differentiation  
After one week of culture on patterned or non-patterned substrates, the surfaces were gently 
transferred to new 12-well plates.  Cells were trypsinized and reseeded into 24-well plates with 
basal media (DMEM supplemented with 10% FBS, 1% p/s).  After 1 day, cells were either fixed 
and assessed for markers, or further subjected to basal media, osteogenic media (low glucose 
DMEM containing FBS, Gentamicin/Amphotericin, L-glutamine, dexamethasone, ascorbate and 
β-glycerophosphate) or adipogenic media (Induction (days 1-3 and 5-7): high glucose DMEM 
containing FBS, Gentamicin/Amphotericin, L-glutamine, dexamethasone, indomethacin, 3-
isobutyl-1-methylxanthine and insulin; Maintenance (day 4): low glucose DMEM containing FBS, 
Gentamicin/Amphotericin, L-glutamine and insulin).  For osteogenic differentiation, osteogenic 
induction media was prepared according to manufacturer’s  instructions (Lonza) and added to 
specific culture wells.  Cells from non-patterned surfaces were seeded at a density ~5000 
cells/cm2, while cells from patterned surfaces were seeded at a density ~2000 cells/cm2.  Media 
was changed every 3 days for 10 days.  For adipogenic differentiation, adipogenic induction and 
maintenance media was prepared according to manufacturer’s (Lonza) instructions.  Culture 
wells were cycled with induction/maintenance media every three days for ten days. 
Characterization of human MSCs 
18 
 
Mesenchymal phenotype was assessed by staining for mesenchymal markers endoglin/CD105 
and Stro-1.  Cell proliferation was assessed via BrdU staining.  Osteogenic and Adipogenic 
differentiation was assessed via alkaline phosphatase and oil red o staining respectively.  All 
imaging was performed on an IN Cell Analyzer 2000 (GE).  20 fields of view were taken for 
every sample condition.  Quantification was performed using ImageJ. 
BrdU staining 
After 1h postseeding, non-adherent cells were aspirated and BrdU labeling reagent (Invitrogen) 
was added to DMEM supplemented with 10% FBS, 1% p/s at a concentration of 1:100 (v/v), 
and incubated for 24h.  After washing with PBS, cultures were fixed in 70% ethanol for 30 min 
followed by PBS rinsing. Cultures were then denatured with 2M HCl for 30 min. followed by PBS 
rinsing.  Cultures were permeabilized with 0.1% Triton X-100 in PBS for 30 min. and blocked 
with 1% BSA in PBS for 15 min.  Cultures were then incubated with mouse anti-BrdU primary 
antibody (1:200 dilution, 3 hours at room temperature) followed by Alexa Fluor 647-conjugated 
anti-mouse IgG antibody (1:200 dilution, 1 hour at room temperature).  Cell nuclei were stained 
with DAPI (1:5000 dilution).  Images of the DAPI and 647 channels were overlayed and percent 
incorporation of BrdU was counted manually. 
Histochemical staining 
To detect alkaline phosphatase activity, fixed cells were incubated in a BCIP/NBT solution 
(Amresco) overnight at room temperature.  Cultures were then rinsed with PBS and imaged with 
brightfield microscopy.  To detect lipid vacuoles, fixed cells were rinsed with 60% isopropanol 
for 5 min.  60% Oil red O stock (300mg Oil Red O powder in 100mL 99% isopropanol) was 
diluted in dH2O, filtered through a 20µm syringe, and added to cells for 30 minutes.  Cells were 
rinsed thoroughly and imaged.  Brightfield and DAPI channels were overlayed and the 
percentage of cells stained positive was counted manually. 
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Immunocytochemistry  
Cells were fixed with 4% paraformaldehyde for 20 minutes, permeabilized with 0.1% Triton X-
100 in PBS for 30 minutes, and blocked with 1% BSA for 15 minutes.  Primary antibody labeling 
was performed in 5% goat serum containing 1% BSA in PBS overnight at 4 °C with rabbit anti-
endoglin (Sigma, 1:200 dilution) and mouse anti-Stro-1 (R&D Systems, 1:200 dilution).  
Secondary antibody labeling was performed similarly with Tetramethylrhodamine-conjugated 
anti-rabbit IgG antibody and Alexa Fluor 647-conjugated anti-mouse IgG antibody (1:200 
dilution) along with Alexa Fluor 488-phalloidin (1:200 dilution) and DAPI (1:5000 dilution) for 1 
hour at room temperature.  Immunofluorescent images were analyzed using ImageJ .  Regions 
of interest were selected by outlining actin filaments for non-patterned surfaces, or by manually 
selecting patterned cells.  For the regions of interest, images were thresholded to select 
positively stained areas and integrated density (representing mean grayscale times feature 
area) was calculated.  DAPI staining was used to count nuclei.  Integrated density was totaled 
for each condition and normalized to cell number to give intensity per cell (arbitrary units).  At 
least two independent experiments each with duplicate samples were performed to verify 
results.  Each condition analyzed represent 100-3000 cells. 
2.3  Results and discussion 
Assessment of DNA synthesis in mesenchymal stem cells 
We used microcontact printing of alkanethiolates on gold as a model system because this 
platform shows high fidelity of pattern formation and stability under physiological conditions for 
up to a week [91,92]. After microcontact printing of octadecanethiol and overnight immersion in 
the tri(ethylene glycol) undecanethiol solution we can visually observe regions of differential 
wetting characteristics indicative of patterning (data not shown). X-ray Photoelectron 
Spectroscopy (XPS) analysis of our surfaces demonstrate formation of tri(ethylene glycol) self-
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assembled monolayers (Figure 2.1). Previous studies have demonstrated the reproducible 
physisorption of matrix protein to the micropatterned octadecanthiol regions using this 
microcontact printing method [93].  A study by Langer et al. on the stability of undecanethiol 
monolayers in PBS and serum conditions also found that although desorption was the most 
likely cause of monolayer failure, this loss was not significant until about 2 weeks in serum 
conditions [94], in line with previous studies which showed pattern loss after about 2 weeks [95].  
We seeded our patterned surfaces immediately after fabrication, and noticed no significant 
change in patterned cell morphology after 6 days in culture.  
Previously, we showed how MSCs can be cultured on microislands fabricated with soft 
lithography for over a week without dividing and that these cells could undergo differentiation 
when exposed to soluble lineage guidance cues [61]. To determine if micropatterned cells 
become quiescent, we performed a bromodeoxyuridine incorporation assay. 1000µm2 islands of 
alkanethiols were microcontact printed onto gold coated coverslips and adsorbed with 
fibronectin to provide adhesion sites for cells (Figure 2.2A).  MSCs were cultured in DMEM low 
glucose media containing a BrdU labeling reagent for both 4 hours and 24 hours. Even at the 
extended time point of 24 hours, only 0.9% ± 1.3% of cells cultured in patterns were stained 
positive for BrdU compared to 21.6% ± 3.8% of cells cultured on fibronectin adsorbed gold 
(Figure 2.2B). 
Expression of mesenchymal stem cell markers Stro-1 and endoglin 
The results of the BrdU incorporation assay suggest that MSCs are in a quiescent state when 
confined to microislands.  To determine if these patterned cultures show any differences in 
expression of MSC markers, we fixed and immunostained MSCs for Stro-1 and endoglin after 
24 hours in patterned and non-patterned culture.  On the patterned surfaces only cells that were 
confined to patterned regions were counted.  Cells within patterned regions displayed markedly 
higher intensities for Stro-1 (Figure 2.3A) and endoglin (Figure 2.3E) than cells cultured on non-
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patterned surfaces (Figure 2.3B, 2.3F).  To ensure this higher intensity was not an imaging 
artifact due to the constrained cell body, after 1 week in culture MSCs were trypsinized from 
patterned and non-patterned surfaces and reseeded into fresh 24-well tissue culture plates.  1 
day after reseeding, subsets of cells that had been previously cultured in patterned and non-
patterned surfaces were fixed and stained.  MSCs that had previously been confined to 
1000µm2 islands displayed higher intensities of Stro-1 (Figure 2.3C) and endoglin (Figure 2.3G) 
than MSCs previously cultured on non-patterned surfaces (Figure 2.3D, 2.3H).  6 days post 
reseeding, MSCs that had previously been confined to patterned islands continued to display 
higher levels of Stro-1 (Figure 2.3I) and endoglin (Figure 2.3K) than MSCs cultured on non-
patterned islands (Figure 2.3J, 2.3L).   
In vitro differentiation of MSCs 
Mesenchymal stem cells are known to spontaneously differentiate into osteogenic lineages 
when cultured on rigid substrates[96].  Since differentiation of stem cells involves asymmetric 
division and our patterned cells do not divide when captured in microislands, we reasoned that 
patterning may restrict spontaneous differentiation. To determine if patterning influences the 
expression of markers associated with osteogenesis we stained MSCs for alkaline phosphatase 
production after reseeding from initial patterned or non-patterned surfaces.  Analysis of the 
fraction of MSCs expressing alkaline phosphatase reveals that the non-patterned culture 
contains greater than twice the number of cells expressing this early osteogenic marker 
compared to cells that were initially cultured in patterns (Figure 2.4).   
To assess whether cells initially cultured in patterned and non-patterned surfaces still 
maintained multipotency, a subset was further cultured in osteogenic and adipogenic induction 
media for 10 days.  Cells cultured in media containing the osteogenic supplements 
dexamethasone, ascorbic acid and β-glycerolphosphate displayed enhanced alkaline 
phosphatase production compared to DMEM basal media (> 5-fold; Figure 2.5). While both 
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previously patterned and non-patterned cells maintained the ability to differentiate, MSCs that 
had been cultured in patterns showed lower levels of alkaline phosphatase staining compared to 
MSCs from non-patterned surfaces after 1 week in culture. This trend is consistent with that 
observed in basal media.  When cultured in media formulated to promote adipogenesis 
(containing dexamethasone, indomethacin and insulin) both previously patterned and non-
patterned MSCs show comparable numbers of lipid vacuoles after 1 week (Figure 2.5).   
Inhibition of Myosin II and ROCK 
Previous studies have suggested that cellular microenvironments that promote low actomyosin 
contractility, promote MSC quiescence [88,90]. Small micropatterns have been shown to foster 
a low degree of cytoskeletal tension in patterned MSCs; thus we sought to determine whether 
the increase in Stro-1 and endoglin intensity of cells cultured in 1000µm2 islands is due to a 
mechanotransduction event corresponding to decreased cell contractility.  Blebbistatin, an 
inhibitor of myosin II, and Y-27632, an inhibitor of Rho-associated protein kinase (ROCK), have 
been shown to reduce cell contractility and decrease the fraction of cells undergoing 
osteogenesis in patterned shapes [61].  We cultured cells on either patterned surfaces in DMEM 
basal media, or non-patterned surfaces in DMEM basal media  supplemented with 1µM 
blebbistatin or 2µM Y-27632 for one week before being reseeded into 24-well plates and 
cultured in DMEM basal media.  After 1, 6, and 16 days following reseeding, cells were fixed 
and stained for Stro-1 and endoglin.  After 1 day following reseeding, MSCs originally cultured 
on patterned surfaces display higher intensity of Stro-1 and endoglin than MSCs cultured on 
non-patterned surfaces with or without the addition of blebbistatin or Y-27632.  Stro-1 and 
endoglin intensity between cells with or without blebbistatin and Y-27632 remain similar (Data 
not shown).  After 6 and 16 days, we observe elevation of Stro-1 and endoglin for cells that 
were previously treated with blebbistatin and Y-27632 compared to non-patterned cells without 
drug treatment (Figure 2.6).   
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Discussion 
In this chapter, we demonstrate that by capturing MSCs to small islands we restrict the 
inappropriate lineage commitment often observed in culture and promote the multipotent stem 
cell phenotype.  From earlier work, we noted that MSCs do not divide when confined to small 
area islands [61].  This observation is in line with previous work by Chen et al. where they 
demonstrated that restricting cell spreading decreases DNA synthesis [97].  We reasoned that 
arresting cellular division may also influence the expression of mesenchymal stem cell markers.  
MSCs are routinely characterized by positive expression of markers such as CD31,CD44,  
CD90, Stro-1, endoglin, CD106, and CD166 [98,99]. In particular, the expression of  endoglin 
[100,101] and Stro-1 [90,102,103] have been extensively used as phenotypic markers of 
mesenchymal stromal cell multipotency.  MSCs have been shown to express similar levels of 
endoglin in early and late passage MSCs [104,105]; however, other reports suggest higher 
expression during early passages compared to senescent passages [106,107].  Similarly, Stro-1 
has been shown to be downregulated in prolonged culture [69].  We show that MSCs confined 
to small 1000µm2 islands express higher levels of endoglin and Stro-1 compared to cells 
cultured on non-patterned surfaces.  Expression of these markers persists even after the cells 
are removed from the islands after a week, and cultured on tissue culture plastic for up to 16 
days.  In addition, MSCs cultured without confinement show higher levels of osteogenesis 
markers suggesting that inappropriate differentiation occurs when they are allowed to proliferate 
under standard cell culture conditions. MSCs that were previously patterned retain their 
multipotency as assayed by in vitro differentiation in adipogenic and osteogenic media.  
One important aspect of MSC culture that has been shown to promote differentiation in vitro is 
the physical properties of the substrate and how this influences cell spreading. For instance, 
MSCs cultured on stiff substrates are well spread, with high cytoskeletal tension, and express 
high levels of bone cell markers [55].   In contrast, cells on soft substrates are less spread, have 
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low cytoskeletal tension and become quiescent [88]. Chen and colleagues further explored cell 
spreading  during osteogenesis by micropatterning single cells in islands of different adhesive 
area [62].  When exposed to a mixed media of soluble differentiation cues, MSCs with high 
spreading in large islands preferred to adopt an osteoblast outcome while cells with low 
spreading in small islands preferred to undergo adipogenesis. In the subsequent years, 
researchers have varied cell geometry [61], micro and nanotopography [108,109] and adhesion 
ligand affinity [110] to demonstrate that conditions that increase cytoskeletal tension all tend to 
promote osteogenesis.  Here we show that under normal MSC culture conditions, there is an 
increase in the fraction of cells that express early osteogenesis markers. We hypothesize that a 
subset of highly spread MSCs have a high degree of cytoskeletal tension that promotes 
differentiation. In contrast, when MSCs are cultured in small microislands they exhibit low 
cytoskeletal tension, become quiescent, and increase the expression of mesenchymal stem cell 
markers Stro-1 and endoglin.  Although we did not measure cytoskeletal tension directly, 
previous reports have demonstrated high cytoskeletal tension is linked to cell spreading [61,62].  
Mesenchymal stem cells cultured in the presence of a myosin II and ROCK inhibitor 
(blebbistatin and Y-27632 respectively), both shown to reduce actin cytoskeleton organization 
[111],  show a similar trend in elevated MSC marker expression.  Taken together, these results 
suggest that reduced actomyosin contractility is important for maintenance of the MSC 
phenotype. 
Previous studies using a number of stem cell systems supports our hypothesis that cell shape 
and cytoskeletal tension are important parameters in promoting multipotency.  Prockop and 
colleagues have demonstrated that subpopulations of small and rapidly self-renewing MSCs 
have higher multipotentiality than their larger and more spread counterparts [112,113].  
Likewise, studies on human embryonic stem cells have shown that compact, rounded hESCs 
exhibit higher expression of pluripotent transcription factors than flattened ESCs [114].  In 
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addition, embryonic stem cell self-renewal is promoted by soft substrates [115] or by using the 
ROCK inhibitor Y-27632 [116,117]. Dalby and colleagues observed lower levels of myosin 
expression on their nanostructued substrates that promote multipotency, further supplementing 
our findings that lower cytoskeletal tension is required to maintain stemness in MSCs [103] . 
These results all indicate the importance of cell spreading and low cytoskeletal tension in 
maintaining multipotency.  Since cells cultured in small islands have considerably lower 
cytoskeletal tension compared to spread cells on the non-patterned substrates, we speculate 
that low actomyosin contractility will not only influence differentiation—as demonstrated 
previously using micropatterned MSCs [61,62] — but may also preserve or even enrich the 
stem cell phenotype.   
Design of novel biomaterial platforms that may enhance in vitro lifetime of MSCs offers 
promising applications for both cell culture and tissue engineering.  Conventional culture 
methods allow for quick expansion, but at the cost of altering phenotype.   Evidence that stiff 
substrates directly alter stem cell fate [55] highlights the importance of tailoring the cell culture 
substrate for a desired application.  We demonstrate that restricting cell shape may be a key 
factor in maintaining multipotency, and one can imagine that culture conditions restricting cell 
spreading either through substrate stiffness, chemistry, or topography may be used to prolong 
the MSC phenotype during ex vivo culture.  Similarly, these studies will serve to guide the 
design of 3D biomaterials where control of cell adhesion and spreading may prove important for 
the success of regenerative therapies and tissue engineering. 
2.4  Conclusion 
Cell shape and actomyosin contractility have been demonstrated to play a key role during MSC 
fate decisions.  Here we show that MSCs cultured under conditions that promote low 
cytoskeletal tension—either through culture in small microislands or with small molecule 
inhibitors of actomyosin contractility—display elevated expression of stem cell markers 
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compared to standard culture conditions (cell culture plasticware).  After release from the 
patterns, MSCs proliferate and maintain multipotency to differentiate to adherent cell lineages. It 
is tempting to speculate that geometric constraints that promote low actomyosin contractility 
recapitulate aspects of the MSC niche architecture for conserving the stem cell phenotype. 
Nevertheless, this study demonstrates the importance of cell shape in maintaining “stemness” 
and provides a new strategy to maintaining MSC multipotency via the use of microengineered 
substrates. Considering the inappropriate differentiation and loss of multipotency commonly 
observed during ex vivo expansion of MSCs in the clinic, there is a need for new platforms that 
promote the stem cell phenotype in vitro. The approach presented here adds to the suite of 
materials-based tools to facilitate the ex vivo culture of autologous cells for regenerative 
medicine and tissue engineering. 
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2.5 Figures 
 
 
 
Figure 2.1 XPS Spectra narrow scan of the C 1s region shows background levels of hydrocarbons on bare gold 
(left).  After immersion in tri(ethylene glycol) undecanethiol, an additional peak appears indicating the C-O bond. 
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Figure 2.2 Patterned mesenchymal stem cells are quiescent. (A): Microcontact printing of self-assembled 
monolayers on thin layers of transparent gold was performed to capture cells on hydrophobic islands containing 
physisorbed fibronectin protein.  Images show MSCs on patterns (top) and unpatterned (bottom) 
immunostained for DAPI (blue) and anti-BrdU (red) (B): After 24 hours, MSCs seeded on patterns showed little 
BrdU incorporation compared to unpatterned cells.  Mean values shown ± standard deviation; *p<0.05.  2 
separate experiments were performed with 20 fields of view taken for each sample.  75 patterned and 507 
unpatterned cells were counted in the first experiment.  144 patterned and 337 unpatterned cells were counted 
in the second experiment.  
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Figure 2.4 Patterned mesenchymal stem cells express lower levels of alkaline phosphatase compared to 
unpatterned cultures. MSCs seeded in patterns were trypsinized and recultured on 24 well plates.  After 1 day 
their spontaneous differentiation into osteogenic lineages was assessed with ALP staining. *p-value < 0.05 by 
one-way ANOVA. 
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Figure 2.5 Patterned MSCs retain multipotency and differentiate to fat and bone.  Cells were incubated with 
osteogenic or adipogenic induction media for 10 days and stained for Alkaline Phosphatase (top), and Oil Red O 
(bottom).  
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Figure 2.6 Mesenchymal stem cells treated with pharmacological inhibitors of actomyosin contractility show 
elevation of multipotency markers. MSCs are cultured for one week either on patterned surfaces, or non-
patterned surfaces with or without the addition of Y-27632 or blebbistatin, then trypsinized and reseeded into 24-
well plates.  After 6 days (top), and 16 days (bottom), cells from the previous conditions are fixed and stained. 
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CHAPTER 3 
CELL SHAPE AND THE PRESENTATION OF ADHESION LIGANDS GUIDE SMOOTH 
MUSCLE MYOGENESIS2 
3.1 Introduction 
Smooth muscle cells (SMCs) are found within the walls of blood vessels and multiple other 
tissues.  Their primary function involves contraction and they serve important roles during 
vascular development. Functional smooth muscle cells are thereby critical for cell-based 
therapies involving vasculogenesis and vascular diseases[118]. Mesenchymal stem cells 
(MSCs) serve as an attractive cell source for smooth muscle due to their relative ease of 
acquisition and culture[75] compared to SMCs[119]. Whereas vascular smooth muscle cells are 
typically derived by removing the endothelial layer of blood vessels to extract the underlying 
sheets of smooth muscle cells[120], MSCs can be acquired from a wide variety of cell sources 
and separated through simple isolation procedures[65] for expansion and differentiation to a 
smooth muscle phenotype. 
MSCs have been shown to commit to a wide array of lineages through control of biophysical 
and biochemical properties including cell geometry[62,61,121], substrate rigidity[122], and 
matrix composition[123,124]. Heterogeneous populations of isolated MSCs will contain a 
fraction of cells that express SMC markers, and there are several microenvironment factors that 
are believed to contribute to the SMC phenotype including soluble factors, extracellular matrix 
components, and physical cues[125]. MSCs have been differentiated into SMCs via direct 
treatment with TGFβ[126], PDGF[127], and a variety of other biocompounds[125].  Direct 
interaction with the extracellular matrix (ECM) has been shown to be equally important to 
 
2This chapter is adapted from the following publication:   
Douglas Zhang, Michael B. Sun, Junmin Lee, Amr A. Abdeen, and Kristopher A. Kilian, Cell shape and the presentation of adhesion 
ligands guide smooth muscle myogenesis, Journal of Biomedical Materials Research: Part A, 2016, 104 (5), 1212-1220. 
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promoting smooth muscle phenotypes. Early reports have demonstrated that fibronectin, 
typically found in serum and used to coat culture substrates, supported a loss of the SMC 
contractile phenotype[128] whereas basement membrane proteins such as laminin and type IV 
collagen could delay this transition[129]. Another study demonstrated that exposing MSCs to 
endothelial cell matrix[130] could induce those cells to differentiate towards a SMC phenotype. 
Likewise the mechanical environment has also been shown to be important in determining SMC 
phenotype. Researchers have demonstrated how MSCs respond to mechanical stimulation 
through compressive strain[131] and alignment[132] to guide specification of markers 
associated with the smooth muscle phenotype. Combinatorial tools that can explore the 
interplay between ligand presentation and mechanical stimulation offer an attractive method to 
decouple the complex mechanisms that modulate SMC differentiation and phenotypic behavior. 
Microcontact printing of self-assembled monolayers (SAMs) is a widely used tool that allows 
manipulation of the biophysical and biochemical properties of cell culture materials. Traditionally 
self-assembled monolayers are produced using long-chain alkanethiolates that are patterned 
onto a gold surface[91,133], followed by passivation of the intervening regions, and location-
specific adsorption of an ECM protein such as fibronectin, collagen, or laminin. Although long-
chain ECM molecules are useful for promoting cellular adhesion, these proteins are known to 
contain multiple binding domains and configurations.  Depending on the local environment, 
these proteins can exist in different conformations, have binding sites buried or exposed, or 
interact with synergistic and antagonistic local domains[134,1]. Smooth muscle in particular, is 
known to be sensitive to ECM properties, where differentiation and maintenance of a contractile 
phenotype is affected by the protein components[125,130] and local environment[126]. These 
interactions between cell and substrate can be biochemical as well as mechanical. 
Environmental cues such as stiffness and topography, and changes in adhesion ligands or 
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restriction of cell size, all affect the contractility of actin and its motor myosin II, to direct cells to 
undergo specific processes. 
In this chapter we present an alternative approach to conventional microcontact printing, where 
incorporation of an azido-terminated alkanethiolate into the printing solution enables patterning 
of specific peptides on the surface of our SAMs. The use of short peptides for surface 
modification presents several advantages over the use of whole proteins.  Peptides are cost-
efficient, easy to synthesize and purify, and able to be conjugated in a spatially defined 
manner[40]. Furthermore, short peptides presented on inert backgrounds allow the 
unambiguous study of discreet ligand-receptor interactions. We demonstrate how subtle 
changes in peptide presentation, from a linear to a cyclic variant of RGD, will influence focal 
adhesion dynamics and the differentiation of MSCs toward a smooth muscle phenotype. We 
examine the interplay between ligand-integrin affinity and cell geometry and find that changing 
the aspect ratio of single cells will influence the spatial guidance of focal adhesions, and that 
intracellular signaling pathways respond to shape and ligand differently.  
3.2 Materials and methods 
Materials 
Glass coverslips were purchased from Fisher Scientific.  All chemicals, unless noted otherwise, 
were purchased from Sigma Aldrich.  11-(2-{2-[2-(2-azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-
undecane-1-thiol (referred to herein as HS-C11-EG4-N3) was purchased from Prochimia 
(Sopot, Poland, TH 008-m11.n4-0.2). Triethylene glycol mono-11-mercaptoundecyl ether 
(referred to herein as HS-C11-EG3) was purchased from Sigma Aldrich (673110).  Tissue 
culture plastic ware was purchased from Fisher Scientific.  Peptide synthesis reagents and 
amino acids were purchased from Anaspec.  Cell culture media and reagents were purchased 
from Gibco.  Human mesenchymal stem cells (hMSCs) were purchased from Lonza and 
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produced by Osiris Therapeutics, Inc. These cells were derived from bone marrow isolated from 
the iliac crest of human volunteers.   
Peptide synthesis 
The peptide sequence GRGDS was synthesized manually by standard Fmoc solid-phase 
methodology as previously described. The synthesized peptide was purified (>90%) using 
reversed-phase high-performance liquid chromatography (RP-HPLC) (Perkin-Elmer Flexar) with 
a C18 column (Waters).  The cyclic peptide RGD{d-Phe}{propargyl-Gly} was purchased from 
Genscript (>90%) and used as received.  
Surface preparation 
Surfaces were fabricated by electron beam evaporation of 5nm of Ti followed by 20nm of Au 
onto cleaned glass coverslips.  These were stored in a desiccator for up to 1 week before use. 
To create patterned surfaces, polydimethylsiloxane (PDMS, Polysciences, Inc.) stamps were 
fabricated by polymerization upon a patterned master of photoresist (SU-8, MicroChem) created 
using UV photolithography through a laser printed mask. Stamps featuring four different 
patterns (circular 1:1, oval 1:2, oval 1:4, oval 1:8) of 3000µm2 were used.  Stamps were inked 
with the inking solution consisting of 15 mol% HS-C11-EG4-N3, 85 mol% HS-C11-EG3 in 
ethanol (1mM total), dried under air, and applied to the surface of the gold.  Surfaces were then 
rinsed with ethanol, dried, and incubated overnight with 1mM HS-C11-EG3 in ethanol to prevent 
non-specific adsorption to non-patterned regions.   
Peptide conjugation 
Stock solution of linear and cyclic peptide ligand (1mM in H2O) and Tris[(1-benzyl-1H-1,2,3-
triazol-4-yl)methyl]amine (TBTA) (10mM in DMSO/t-butyl alcohol (3:1)) were aliquoted and 
stored at -20°C. Copper solution (10mM Cu, 10mM sodium ascorbate in DMSO) was prepared 
fresh prior to click modification.  Click solution was prepared by combining stock TBTA solution 
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with fresh Cu solution (2:1 v/v).  Reaction mixtures containing peptide ligand (5µL) and click 
solution (5µL) were prepared and reacted with patterned surfaces overnight at room 
temperature.  The surfaces were then placed into 24-well plates, rinsed 2x with DI water, 
incubated with 50mM EDTA for 5 min to remove residual copper, and finally rinsed 3x with DI 
water followed by ethanol.   
Cell culture 
Human mesenchymal stem cells (hMSCs) were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) low glucose (1g/mL) media supplemented with 10% fetal bovine serum (MSC 
approved FBS; Invitrogen), 1% penicillin/streptomycin (p/s), media changed every 3-4 days and 
passaged at ~80% confluency using 0.25% Trypsin:EDTA (Gibco). MSCs were seeded on 
patterned and non-patterned surfaces at a cell density ~20,000 cells/cm2 and cultured for 5 days 
before fixing. For pharmacological inhabitation studies, we used Blebbistatin (10µM), Y27632 
(10 µM), Calpain Inhibitor I (130 µM, Sigma A6185), and Rac Inhibitor II (50 µM, CAS 1090893-
12-1, Calbiochem). MSCs were tested for purity by Lonza, and were positive for CD105, CD166, 
CD29, and CD44, negative for CD14, CD34, and CD45 by flow cytometry, and had ability to di-
fferentiate into osteogenic, chondrogenic, adipogenic lineages (http://www.lonza.com).  The use 
of human MSCs in this work was reviewed and approved by the University of Illinois at Urbana-
Champaign Biological Safety Institutional Review Board. 
Immunocytochemistry 
Cells were fixed with 4% paraformaldehyde (PFA) for 20 minutes, permeabilized with 0.1% 
Triton X-100 in PBS for 20 minutes, and blocked with 0.1% bovine serum albumin (BSA) in PBS 
for 30 minutes.  Primary antibody labeling was performed in 5% goat serum containing 0.1% 
BSA in PBS overnight at 4°C with rabbit anti-paxillin (1:200 dilution, abcam ab32084), mouse 
anti-α5β1 (1:200 dilution, Millipore MAB1969), mouse anti-αvβ3 (1:200 dilution, Millipore 
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MAB1976Z), mouse anti-αSMA (1:200 dilution, abcam ab7817). Secondary antibody labeling 
was performed similarly with Alexa Fluor 488-conjugated anti-rabbit IgG antibody and Alexa 
Fluor 647-conjugated anti-mouse IgG antibody (1:500 dilution) along with Texas Red-
conjugated phalloidin (1:200 dilution) and DAPI (1:5000 dilution) for 1 hour at room temperature.  
Surfaces were fixed on glass slides using Prolong Gold Antifade (Thermo Fisher) and imaged 
with an INCell Analyzer 2000 (GE).   
RNA isolation and RT-PCR 
MSCs were cultured on linear and cyclic-RGD presenting SAMs for 24 hours.  Adherent cells 
were lysed with TRIZOL reagent (Invitrogen) and total RNA was isolated by chloroform 
extraction and ethanol precipitation. Total RNA in DEPC water was amplified using TargetAmp 
1-Round aRNA Amplification Kit 103 (Epicentre) according to vendor protocols. Total RNA was 
reverse transcribed using Superscript III First Strand Synthesis System for RT-PCR (Invitrogen). 
RT-PCR was performed linearly by cycle number for each primer set using SYBR Green 
RealTime PCR Master Mix (Invitrogen) on an Eppendorf Realplex 4S Real-time PCR system. 
Primer sequences were as follows (forward and reverse):  
α5: TGCCGAGTTCACCAAGACTG and TGCAATCTGCTCCTGAGTGG 
αv: CATCTTAATGTTGTGCCGGATGT and TCCTTCCACAATCCCAGGCT 
β1: CCGCGCGGAAAAGATGAATTT and AGCAAACACACAGCAAACTGA 
β3: TTGGAGACACGGTGAGCTTC and GCCCACGGGCTTTATGGTAA 
GAPDH: TGCCTCGATGGGTGGAGT and GCCCAATACGACCAAATCAGA 
Image analysis 
Immunofluorescent images were analyzed using ImageJ software. To count α-SMA positive and 
negative cells, the channel staining for α-SMA was overlayed over the nuclei channel.  Nuclei 
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that stained positive for α-SMA was counted manually and subtracted from the total number of 
nuclei. For patterned cells, only cells conforming to the pattern shapes were chosen for 
analysis.  For heat maps, cells were overlayed and a z-project was taken for the average 
intensity. Masks of heat maps were generated by normalizing the backgrounds and thresholding 
the results of the z-projection. At least two independent experiments with triplicate samples 
were performed to verify results.  To calculate p-values, the results of all experiments were 
pooled and a Fisher’s exact test was performed on the ratios of α-SMA+ cells using GraphPad 
software.  
3.3 Results and discussion  
Patterning peptide derivatized self-assembled monolayers on gold surfaces 
We found that an ethanoic solution containing an azido-terminated tetra(ethylene glycol) 
alkanethiolate (HS-C11-EG4-N3) could be micropatterned similar to traditional long-chain 
alkanthiolates.  Self-assembled monolayers patterned this way supported cell adhesion in 
defined geometries for over 2 weeks in culture (Figure 3.1). After backfilling non-patterned areas 
with a tri(ethylene glycol) alkanethiolate to resist non-specific protein adsorption (HS-C11-EG3), 
surfaces can be further modified with alkyne-containing peptides using copper-catalyzed alkyne-
azide cycloaddition (CuAAC) to generate well defined geometries of peptide-adhesion ligands 
(Figure 3.2). Importantly, patterning the non-adhesive RDG peptide resulted in negligible cell 
adhesion (data not shown). We investigated four geometries with varying aspect ratios and 
used a low affinity linear version and a high affinity cyclic version of the RGD peptide[135,110] 
to investigate the combined effect of ligand affinity and geometry on the differentiation of MSCs 
toward a smooth muscle phenotype. 
Mesenchymal stem cell phenotype changes on peptide-presenting SAMs 
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MSCs cultured on the linear and cyclic RGD peptide surfaces exhibited phenotypic differences 
in cell spread area (Figure 3.3). We immunostained the MSCs for α-smooth muscle actin 
(αSMA), a key marker of smooth muscle differentiation, and found that a higher fraction of 
MSCs cultured on the cyclic RGD peptide expressed αSMA when compared to MSCs cultured 
on linear RGD (Figure 3.3). This trend was consistent for up to 10 days in culture. The 
differences in cell size was also accompanied by changes in the focal adhesion architecture of 
the adherent cells. MSCs cultured on cyclic RGD displayed smaller focal adhesion complexes 
(Figure 3.4a, 3.4b), with an increased average number of focal adhesions per cell, although this 
result was not significant (p=0.07). These observations are consistent with earlier reports of 
smaller focal adhesions and higher focal adhesion turnover for cells cultured on cyclic RGD, 
compared to linear RGD where cells adopt larger, more stable focal adhesions at the 
perimeter[136]. Interestingly, we also noticed differences in integrin expression between MSCs 
cultured on the two peptides. We immunostained for α5β1 and αvβ3 integrin, receptors that are 
commonly expressed in MSCs and can adhere to a variety of RGD-based peptide motifs[137], 
and observed no significant changes in α5β1 expression between MSCs cultured on the linear or 
cyclic variant of RGD.  However, we detected significantly higher αvβ3 integrin expression when 
MSCs were cultured on the cyclic peptide (Figure 3.4c). We also measured initial integrin mRNA 
expression of MSCs 24 hours after adhering to the peptide surfaces.  We observe that MSCs 
adhering to linear RGD express significantly higher levels of α5 integrin (Figure 3.4d), while 
MSCs adhering to cyclic RGD express slightly higher levels of αv integrin (Not significant, 
p>0.05). Previous investigators have found that a bent conformation of the RGD sequence 
presents a closer fit to the αvβ3 receptor and leads to improved ligand binding[138]. Our own 
observations then seem to suggest that not only is there an effect of ligand affinity, but 
differences in peptide conformation can also lead to overall differences in integrin expression. 
Since differences in cell spreading are well known to affect downstream signaling[61,62], we 
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employed our peptide patterning approach to normalize cell spread area and to investigate how 
αSMA expression changes with cell shape. 
First we explored how controlling cell geometry may influence the number and size of focal 
adhesions on the cyclic or linear peptides. Heat maps of paxillin-stained patterned cells at one 
and five days show uniform focal adhesions at the perimeter, with a larger focal adhesion 
footprint throughout the body of the cell on cyclic peptide surfaces (Figure 3.5a). This is 
consistent with our earlier work[139] as well as the work of other groups who report on average 
more focal adhesions per cell on cyclic RGD[136]. As aspect ratio is increased we observe focal 
adhesion localization towards the extreme axes of the cells. Previous studies have 
demonstrated stabilization of focal adhesions to the short ends of the cell as aspect ratio is 
increased to stabilize actin filaments along the long edge of the cell through myosin II generated 
tension[140]. From our paxillin-stained heatmaps, we are able to generate a mask to show the 
focal adhesion footprint along the periphery in each condition.  We observe similar average 
intensity of paxillin (data not shown) across all samples, but differences in the “footprint” of how 
the focal adhesions are distributed.  As aspect ratio increases, the focal adhesion footprint 
becomes larger and more localized towards the periphery of the cell.   
When we confine the cells to keep spread area constant and increase the aspect ratio, we 
continue to observe a pattern where the cyclic peptide promotes higher αSMA expression in all 
geometries, with the greatest difference occurring at the 1:4 aspect ratio (Figure 3.6a). 
Interestingly, as the aspect ratio is increased to 1:8, the difference in αSMA expression between 
linear and cyclic peptides is reduced and non-significant at a p-value of 0.05.  We also observe 
an interesting trend in αSMA expression and the focal adhesion footprint. For each aspect ratio, 
cells patterned on cyclic RGD tended to have a greater footprint area than cells on linear RGD, 
with the highest differences in the 1:1 isotropic ratio (p=0.08), and the 1:4 ratio (p<0.05) (Figure 
3.5b). At 1:4 aspect ratio, where there is the most significant difference in αSMA expression due 
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to the peptide alone, there is also the greatest difference in the focal adhesion footprint between 
the cells (Figure 3.6b). At a 1:8 aspect ratio, where the difference in αSMA expression is less 
significant, there is also very little difference in focal adhesion distribution between this 
condition, highlighting the importance of focal adhesion architecture in differentiation processes. 
However, while αSMA expression is normalized between different affinity peptides as aspect 
ratio is increased, total expression of αSMA increases.  
Pharmacological inhibition of mechanotransduction pathways  
Given the differences in focal adhesions, we examined several protein targets that are known to 
be involved in focal adhesion architecture and turnover.  We focused on the 1:1 isotropic pattern 
and the 1:4 aspect ratio pattern as these seemed to be the geometries that elicited the most 
significant differences in α-SMA expression. We investigated Rac1, a well-characterized 
GTPase which drives membrane protrusion and formation of nascent focal complexes[141], 
non-muscle myosin II, a central protein involved in many cell migration and adhesion 
pathways[142], Rho-associated, coiled coil-containing kinase (ROCK), an upstream regulator of 
myosin II[143], and calpain, a protein involved in various biological processes, including 
migration and cytoskeletal remodeling[144,145]. 
Rac is a type of Rho GTPase known to play an important role in adhesion dynamics[140]. Rac1 
is particularly interesting as it has been previously shown to be involved in smooth muscle 
differentiation of MSCs[146]. However, after treating MSC cultures with an inhibitor of Rac1, we 
found no significant differences in α-smooth muscle expression at the 1:1 and 1:4 aspect ratios 
(Figure 3.7). We also use inhibitors of actomyosin contractility – blebbistatin to inhibit myosin II, 
and Y-27632 to inhibit ROCK – and see variable responses.  At low aspect ratio, we see no 
significant effect of either myosin II or ROCK inhibition. However at a high 1:4 aspect ratio, we 
observe ~50% decreases in αSMA expression on both linear and cyclic peptides. Calpain, a 
less studied protease has also emerged as an important mediator of focal adhesion 
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disassembly and turnover[147]. When treated with a calpain inhibitor, we observe a significant 
decrease in αSMA expression in cells cultured on both linear and cyclic peptide substrates, only 
when patterned at high aspect ratio (Figure 3.7).  
Discussion 
We present a technique that allows precise control over both ligand presentation and cell 
geometry and demonstrate that even a small change in ligand presentation (linear vs cyclic) can 
significantly affect the differentiation of MSCs to a smooth muscle phenotype. A cyclic 
conformation of the RGD pentapeptide containing a hydrophobic d-amino acid at the i+1 
position of the βII’-turn and glycine at the i+1 position of the γ-turn has been known to more 
closely resemble the loop domain of vitronectin and fibrinogen that binds to the αvβ3 
heterodimer, and has greater specificity and selectivity in binding to this integrin compared to 
linear RGD peptides[138]. Previous work has shown cyclic RGD to have greater selectivity 
towards the αvβ3 integrin and its downstream signaling pathways[135,110,148,149]. In support 
of these studies, we see increased expression of the αvβ3 integrin on MSCs cultured on the 
cyclic peptide. We also observe a similar effect as has been reported by Kato and Mrksich 
where MSCs cultured on the linear peptide had larger focal adhesions, while MSCs on cyclic 
RGD had a greater number of smaller focal adhesions[136]. We observe no significant 
difference in α5β1 integrin expression on linear compared to cyclic RGD substrates.  We see a 
similar trend in MSC integrin expression on linear and cyclic peptides at both the protein (based 
on immunofluorescence) and mRNA level, though we detect statistically significantly higher αvβ3 
expression via immunofluorescence, and statistically significant differences in α5 integrin, but 
not αv mRNA.  We believe these differences may be due to the immunofluorescence being 
performed after 5 days of culture, whereas we chose to measure mRNA expression after 24 
hours of culture. We observe that MSCs on linear RGD initially (after 24 hours culture) express 
significantly more α5 integrin mRNA than MSCs cultured on cyclic RGD.  After 5 days culture, 
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α5β1 integrin expression on linear RGD is also higher via immunofluorescence than α5β1 
integrin expression on cyclic RGD, though the difference is small and not statistically significant. 
However, since our platform presents the RGD peptide in a controlled density and orientation, 
and considering the general trend in integrin expression between the two peptide surfaces, we 
presume that phenotypic changes are influenced largely by the affinity of the ligand for integrin 
receptors.   
Since cellular elongation has been demonstrated to influence the smooth muscle 
phenotype[132], we next explored how altering the aspect ratio of single cells influence the 
interactions of MSCs with these ligands of different affinity. Interestingly, the effects of RGD 
cyclization seem to be most pronounced at 1:4 intermediate aspect ratio. While cyclic RGD 
patterned MSCs express more αSMA than linear RGD patterned MSCs at all aspect ratios, the 
effects are most significant at an aspect ratio of 1:2 and 1:4. The 1:4 aspect ratio is also where 
we observe the greatest difference in the focal adhesion architecture of individually patterned 
cells. Masks of focal adhesion heat maps show that in MSCs cultured on cyclic RGD, paxillin-
stained focal adhesions have a larger “footprint” than on linear RGD.  This corresponds with 
previous observations that cyclic RGD promotes smaller focal adhesions and more rapid 
turnover, whereas linear RGD promotes larger more stable focal adhesions. As cell aspect ratio 
is increased to 1:8 we see the highest αSMA expression, but with attenuation of the influence of 
ligand affinity, which suggests elongation of the cell dominates the smooth muscle phenotype. 
Treatment of MSCs with blebbistatin, an inhibitor of myosin II known to be important in 
determining intracellular tension,[142] as well as regulating contraction in smooth muscle 
through the RhoA/ROCK pathway[150], demonstrates a modest influence on αSMA expression 
(Figure 3.7, Figure 3.8). At a low 1:1 aspect ratio, blocking myosin II through blebbistatin only 
shows a slight influence on αSMA expression (p>0.05) on the cyclic peptide, while at high 1:4 
aspect ratio, we observe no changes in smooth muscle expression after myosin II inhibition.  
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However, inhibition of ROCK, an upstream effector of myosin, caused marked decreases in α-
smooth muscle actin expression at both 1:1 and 1:4 aspect ratios (Figure 3.7).  While previous 
studies have highlighted the importance of the Rho/ROCK pathway in the differentiation of 
MSCs into SMCs[151], in this study we observe an influence of geometry on ROCK signaling 
and enhanced smooth muscle phenotype at high aspect ratio. This result supports previous 
findings of a role for cell shape and stretching in smooth muscle cell proliferation and 
differentiation[152,153].  
A previous study using patterned MSCs concluded that Rac1 activation rather than RhoA 
activation is sufficient to induce smooth muscle differentiation[146]. Well-spread MSCs, when 
activated with TGFβ, underwent SMC differentiation through Rac1 activation.  However, the 
authors used square patterns coated with fibronectin protein. In the present study, we observe 
that Rac signaling may be guided by both ligand affinity and cell aspect ratio during smooth 
muscle myogenesis.  Unlike the authors of the previous study, we observe a small (not 
significantly significant) decrease in αSMA expression after Rac1 inhibition only for MSCs 
cultured on a high affinity/low aspect ratio combination (cyclic RGD/1:1 aspect ratio). This 
observation shows how tuning ligand affinity and cell geometry, independently or together, can 
be used to tune specific signaling pathways towards exploring a desired cellular outcome. 
We observe decreases in αSMA expression in all samples treated with an inhibitor of calpain, 
although changes at a 1:1 aspect ratio were not significantly different from non-treated MSCs. 
Calpains are a family of calcium-dependent proteases that have been linked to a diverse array 
of cellular functions including cell motility and focal adhesion turnover[154,155]. They are less 
studied compared to the Rho GTPases, but have been linked to smooth muscle 
proliferation[156] as well as mechanosensing[157]. A key feature of the Rho, Rac, and calpain 
pathways is their involvement in the regulation of focal adhesion complexes and cytoskeletal 
tension[158,159]. We observe that all three pathways are involved during smooth muscle 
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myogenesis of MSCs as inhibition of any one member appears to alter αSMA expression.  
However, the involvement of these pathways appears dependent on factors such as ligand 
affinity and geometry, underscoring the importance of controlling these conditions when 
studying cellular processes. Central to all three of these signaling molecules is involvement 
during regulation of focal adhesion dynamics.  While we do not measure focal adhesion 
turnover directly in our study, we investigate changes in the focal adhesion architecture and 
footprint at an early (24 hour, Figure S2) and late (5 day, Figure 4) time point. We observe 
changes in focal adhesion architecture that mirrors changes in smooth muscle actin expression. 
Interestingly, though we detect differences in overall integrin expression (Figure 3.4c, 3.4d) we 
observe few differences in integrin localization (Figure 3.9).  We thereby propose a mechanism 
where MSC differentiation towards smooth muscle is influenced by several players in regulation 
of focal adhesion dynamics – Rac, Rho/ROCK, and Calpain – that will be differentially activated 
under specific contexts of microenvironment stimuli. 
3.4 Conclusion 
Patterning matrix proteins across a material is a powerful tool for the study of cell adhesion and 
differentiation. Here we present a microcontact printing method using short peptides that allows 
even greater control over the biophysical and biochemical parameters underlying cell adhesion 
and associated signaling.  We show that even a subtle change in adhesion ligand –a linear 
versus cyclic peptide – can have significant effects on the behavior of adherent MSCs and 
lineage specification to a smooth muscle phenotype.  Pathway analysis reveals the importance 
of several mechanotransduction pathways in mediating smooth muscle myogenesis of MSCs.  
In summary, peptide patterning will allow the investigation of virtually any combination of 
bioactive peptides, at controlled densities across the biomaterials interface, which may afford 
spatial control of cellular processes and differentiation outcomes without the need for soluble 
supplements. 
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3.5 Figures 
 
 
 
 
 
 
 
 
 
Figure 3.1 MSCs cultured for 14 days on linear RGD presenting SAMs.  Even after two weeks in culture media, 
cells remain confined to the patterned (1:2) regions. 
48 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Azido-terminated monolayers were patterned on gold using microcontact printing. a)  A linear (low 
affinity) RGD peptide and cyclic (high affinity) RGD are then conjugated to the surfaces of the patterned 
substrates using copper-catalyzed cycloaddition. b) Four geometries were investigated with the same area 
(3000µm2) but varying aspect ratios. Representative cells cultured on linear RGD patterns are shown. Blue = 
Nuclei, Red = Paxillin, Green = F-Actin 
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Figure 3.3 MSCs cultured on linear and cyclic RGD peptide display phenotypic differences in cell spread area 
after 5 days, and a greater percentage of cells express α-smooth muscle actin when cultured on the cyclic 
peptide. Blue = Nuclei, Red = α-smooth muscle actin, Green = F-Actin. Error bars show SD between two 
independent experiments with three replicates each. P-values calculated using Fisher’s exact test for %positive α-
SMA, * p<0.05, ** p<0.01. Scale bar = 200µm.   
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Figure 3.4 Differences in focal adhesion architecture between MSCs cultured on linear and cyclic RGD. a,b) 
Linear RGD promoted larger individual focal adhesion complexes, while MSCs on cyclic RGD had on average 
more focal adhesions per cell. c) Integrin expression was quantified via immunofluorescence staining after 5 days 
of culture on RGD presenting surfaces. d) Initial integrin mRNA expression after 24 hours is also assessed via 
RT-PCR.  Blue = Nucleii, Red = F-Actin, Green = Paxillin. Error bars show SD between two independent 
experiments. P-values calculated using two-tailed student t-test, * p<0.05, ** p<0.01. Scale bar = 200µm.    
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Figure 3.5 Heat maps of paxillin localization of MSCs cultured on linear and cyclic RGD peptide. a) As aspect 
ratio increases, focal adhesions become localized toward the cell poles. b) Mask of focal adhesion intensity 
shows changes in focal adhesion size and footprint between linear and cyclic peptide.      
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Figure 3.6 MSCs are cultured in patterns presenting either a linear or cyclic variant of RGD. a) After 5 days, 
patterns with higher aspect ratios contained significantly more cells expressing α-smooth muscle actin.  The cyclic 
peptide, known to have higher affinity for the α
v
β
3
 integrin also promotes higher α-smooth muscle actin 
expression compared to the linear peptide.  Differences in expression levels are the most significant at 
intermediate aspect ratios (1:2 and 1:4). b) Based on masks of focal adhesion footprints at each aspect ratio, we 
see the most significant changes in overall area of focal adhesion localization at a low isotropic 1:1 aspect ratio, 
and an intermediate 1:4 aspect ratio. Error bars show SEM between three independent experiments with three 
replicates each.  P-values calculated using Fisher’s exact test, * p<0.05, ** p<0.01.     
 
Figure 3.7 Several protein targets that are known to be involved in focal adhesion architecture and turnover are 
knocked down using pharmacological inhibition.  We see marked changes in expression of α-smooth muscle 
actin with respect to untreated control MSCs.  At a low isotropic aspect ratio (1:1) geometry, we see slight 
decreases in expression with addition of Y27632 (ROCK inhibitor), and Calpain I inhibitor, though these effects 
were not significant.  However, at high aspect ratio (1:4), see significant decreases in expression with ROCK and 
Calpain inhibition.  Error bars show SEM between two independent experiments. P-values calculated using 
student’s t-test between replicate samples, * p<0.05, ** p<0.01.     
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Figure 3.8 At a low aspect ratio (1:2) and very high aspect ratio (1:8) geometry, we see decreases in expression 
with addition of Y27632 (ROCK inhibitor), and Calpain I inhibitor, similar to the trend with 1:1 and 1:4 aspect 
ratios.  Error bars show SEM between two independent experiments. P-values calculated using student’s t-test 
between replicate samples, * p<0.05, ** p<0.01.     
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Figure 3.9 Heatmaps of integrin localization for α5β1 and αvβ3 integrin 
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CHAPTER 4 
PEPTIDE MICROARRAYS FOR THE DISCOVERY OF SURFACES THAT GUIDE CELLULAR 
PROCESSES: A SINGLE STEP AZIDE-ALKYNE “CLICK” CHEMISTRY APPROACH3 
4.1 Introduction 
Autologous stem cells – multipotent cells derived from a patient’s own body – offer broad 
therapeutic potential due to their immunocompatibility, ability to differentiate into multiple cell 
types, and lack of ethical issues related to their derivatization.  Bone marrow derived stem cells 
(BMSCs), first observed by Friedenstein and co-workers[64], are a well characterized cell type 
known to differentiate into multiple cell types important to tissue engineering, including cartilage, 
bone, tendon, and muscle[74,75,160].  Recently, these mesenchymal stem cells have been 
isolated in nearly all tissues and organs in the body[68].  Multipotent stem cells within adipose 
tissue, adipose-derived stem cells (ADSCs) have recently gained popularity as adipose tissue is 
widely available and easily obtainable[161–163].  While these cells hold much promise, precise 
control and understanding of the complex signaling between the cell and the extracellular matrix 
(ECM) will be important for clinical translation.  When biomaterials are exposed to biological 
environments in vivo or growth media in vitro, ECM matrix proteins can nonspecifically adsorb to 
the surface, allowing cells to interact with the biomaterial surface through the adsorbed ECM 
proteins[164].  ECM proteins such as fibronectin, vitronectin, and laminin are often used for 
surface modifications, and combinations of these and other proteins are an attractive strategy 
for recapitulating the complex composition of the in vivo microenvironment.  For instance, 
Langer and colleagues used combinations of leukemia-inhibitory factor, fibronectin, laminin, and 
fibroblast growth factor 4 substrates to investigate murine embryonic stem cell self-renewal and 
 
3This chapter is adapted from the following publication:   
Douglas Zhang and Kristopher A. Kilian, Peptide microarrays for the discovery of surfaces that guide cellular processes: a single 
step azide-alkyne "click" chemistry approach, Journal of Materials Chemistry B, 2014, 2 (27), 4280-4288. 
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differentiation[23].  Bhatia and collegues spotted 32 combinations of five ECM molecules 
(collagen I, collagen III, collagen IV, laminin, and fibronectin) onto acrylamide hydrogels and 
assessed the differentiation of mature, primary rat hepatocytes, and mouse ES cells[31].  Both 
studies showed that ECM molecules can have synergistic as well as antagonistic effects on self-
renewal and differentiation, demonstrating the importance of cross-talk between integrin, growth 
factor, and matrix molecules. 
The discovery that the arginine-glycine-aspartic acid (RGD) amino acid sequence on the binding 
domain of fibronectin could form an essential recognition site for cells[165] spurred research into 
discovering other minimum binding sequences that had similar selectivity for cell integrins.  
Although less effective than whole proteins alone, peptides offer the advantage of being short, 
easily synthesized, and integrin-specific[137]. They are an attractive choice to serve as 
synthetic substrates for modeling extracellular matrix interactions. One of the best and most 
studied systems are self-assembled monolayers (SAMs) of alkanethiolates on gold[133].  SAMs 
form well-ordered close-packed structures in the presence of gold, are straightforward, and 
ECM protein mimetics can be introduced by a simple mixture of terminally substituted 
alkanethiols[40,166].  Hudalla and Murphy for instance, used a mixture of carboxyl and azide 
terminated alkanethiolates to immobilize adhesion peptide RGDSP as well as TYRSRKY in 
order to explore the synergistic effects of these peptides on cell adhesion[167].   
Ligand presentation clearly plays a major role in stem cell fate decision and function, and testing 
single candidate peptides and proteins is instructive, but in order to discover novel ligands, high-
throughput approaches to model ECM are required[168].  Early work by Langer and colleagues 
exploited the use of robotic fluid handling to create arrays of polyacrylate monomers to study the 
effect of polymer-cell interactions[23]. Lutolf and co-workers used a DNA spotter to create cell 
niches microarray spots with modular stiffnesses (1-50kPa) per well, along with various 
combinations of proteins.  They found that certain combinations of ECM adhesion protein, 
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growth factor, and stiffness could influence proliferation, quiescence, and death of neural stem 
cells[56].  Kiessling and colleagues applied SAMs on gold into an array type format investigating 
the effects of various peptide ligands on stem cell culture[46].  Using phage display based on 
the “biopanning and rapid analysis of selective interactive ligands” (BRASIL) technique[48], they 
were able to identify six novel peptides that possessed embryonal carcinoma cell binding 
capabilities[49].  Recently, Yousaf and colleagues microarrayed a variety of small molecules 
and peptides and investigated ligand density effects on the differentiation of MSCs[51]. 
In this chapter we present a microarray strategy using self-assembled monolayers of alkane 
thiolates on gold to form well-defined regions of various combinations of peptides in a single 
step.  The peptides are conjugated to the SAM via copper I catalyzed azide-alkyne “click” 
cycloaddition (CuAAC).  We investigated a cell adhesion peptide (YIGSR), a bone 
morphogenetic protein (BMP) growth factor derived peptide (KPSSAPTQLN), and a heparin 
binding peptide (KRSR).  By varying the ratio of peptides before spotting, we can investigate 
combinatorial effects of these peptides on the adhesion characteristics on two different cell 
types, mouse embryonic fibroblasts (MEFs) and adipose derived stem cells (ADSCs).  This 
biofunctionalization strategy can be applied to any peptide or small molecule containing a 
pendant alkyne group.  We further investigate the differentiation of ADSCs on a combination of 
peptides and show that surfaces presenting the BMP-7 derived peptide alone or in combination 
with other adhesion peptides can enhance osteogenic markers after 3 weeks in standard culture 
media.   
4.2  Materials and methods 
Materials   
Cover glass substrates were purchased from Fisher Scientific.  All chemicals, unless noted 
otherwise, were purchased from Sigma Aldrich, of analytical grade and used as received. 11-(2-
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{2-[2-(2-azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-undecane-1-thiol (referred to herein as HS-C11-
EG4-N3) was purchased from Prochimia (Sopot, Poland, TH 008-m11.n4-0.2).  Triethylene 
glycol mono-11-mercaptoundecyl ether (referred to herein as HS-C11-EG3) was purchased 
from Sigma Aldrich (673110).  Tissue culture plastic ware was purchased from USA Scientific.  
Peptide synthesis reagents and amino acids were purchased from Anaspec.  Cell culture media 
and reagents were purchased from Gibco.  Human adipose-derived stem cells (ADSCs) (PT-
5006) and differentiation media were purchased from Lonza.   Mouse embryonic fibroblasts 
(MEFs) (C57BL/6 4M untreated) were purchased from globalstem.   ADSCs were isolated from 
lipoaspirates collected during surgical liposuction procedures.  ADSCs were tested for purity by 
Lonza, and were positive for CD13, CD29, CD44, CD73, CD90, CD105, CD166 by flow 
cytometry, and had the ability to differentiate into osteogeneic, chondrogenic, adipogenic 
lineages (http://www.lonza.com).  The use of human ADSCs in this work was reviewed and 
approved by the University of Illinois at Urbana-Champaign Biological Safety Institutional 
Review Board. 
Peptide synthesis  
Peptides were synthesized manually by standard Fmoc solid-phase methodology.  N-terminal 
fluorenylmethyloxycarbonyl (Fmoc) protected rink amide resin was deprotected with 20% 
piperidine in N’,N’-dimethylformamide (DMF) for 15 min.  The solvent was filtered with a vacuum 
manifold, and resin was washed 4 times with DMF.  A solution containing 3 equivalents of the 
amino acid, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), and 
N-methylmorpholine in DMF was added to each tube for a 1 h incubation at room temperature.  
The solutions were then filtered, washed 4 times with DMF, and the next Fmoc was 
deprotected.  After all amino acid residues were coupled, the peptides were capped with a 
propargyl-PEG-NHS ester (Quanta Biodesign, 10511) in DMF overnight.  The resin was then 
washed 4 times with DMF and 4 times with ethanol before cleaving with a cocktail containing 
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95% trifluoroacetic acid (TFA), 2.5% H2O, and 2.5% triisopropylsilane (TIS) and incubating at 
room temperature for 3 h.  The resulting solution was evaporated by flowing air over the tube for 
30 minutes.  The resultant precipitate was re-dissolved in 1mL TFA, and re-precipitated in 9mL 
ice-cold diethyl ether.  After 3 additional dissolve-precipitate steps, the residues were dissolved 
in water and lyophilized overnight.  Bioactive peptides Tyr-Ile-Gly-Ser-Arg (YIGSR), Lys-Pro-
Ser-Ser-Ala-Pro-Thr-Gln-Leu-Asn (KPSSAPTQLN, herein referred to as KPSS), Lys-Arg-Ser-
Arg (KRSR), Gly-Arg-Gly-Asp-Ser (GRGDS) and scrambled control peptide Gly-Arg-Asp-Gly-
Ser (GRDGS) were synthesized.  Final products were analyzed with low resolution electrospray 
ionization (ESI) (Waters Quattro II) and semipreparative reversed-phase high-performance 
liquid chromatography (RP-HPLC) (Perkin-Elmer Flexar).  All peptides used were purified to 
>90% purity as assessed by HPLC.  
Surface preparation  
Glass coverslips were cleaned by sonicating 20 min in ethanol and dried under air.  5 nm of Ti 
followed by 20 nm of Au were then deposited on the surface by electron beam deposition.  Gold 
surfaces were stored in a dessicator for up to two weeks before use.  Prior to microarray 
spotting, gold surfaces were cut to fit into 6-well plates, cleaned by briefly sonicating for 1 min in 
glacial acetic acid and 1 min in ethanol, and mounted onto 75x25 mm microscope slides by 
applying a thin layer of ethanol to the interface.  
Microarray printing  
Stock solutions of peptide ligand (1mM in H2O), Tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine (TBTA) (10mM in DMSO/t-butyl alcohol (3:1)), and azide-terminated 
alkanethiolate solution (HS-C11-EG4-N3/HS-C11-EG3, 15% azide mol fraction in ethanol) were 
prepared and stored at -20ºC.  Copper solution (10mM CuBr, 10mM sodium ascorbate in 
DMSO) was prepared fresh prior to click modification.  Click solution was prepared by 
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combining stock TBTA solution with fresh CuBr solution (2:1 v/v).  Reaction vials containing 
peptide ligand (5µL), click solution (5µL), and azide-terminated alkanethiolate solution (10µL) 
were prepared and incubated at 37ºC for 1 h.  These solutions were transferred to a 384-well 
plate and printed in subarray format on the gold-coated surfaces using a Gene Machines OGR-
03 OmniGrid Microarrayer.  The substrate is removed from the microscope slide and thoroughly 
rinsed with DI H2O followed by ethanol.  After 4 rinse steps, printed substrates were immersed 
in a 0.1% Ethylenediaminetetraacetic acid (EDTA) solution for 20 minutes, followed by another 
4 rinse steps.  Substrates were then immersed in a HS-C11-EG3 solution to render the non-
printed regions inert to nonspecific adsorption. 
Long-term SAMs   
Au surfaces were immersed in 15% HS-C11-EG4-N3/HS-C11-EG3 overnight to form 
monolayers.  Surfaces are rinsed with ethanol and cut to fit into 24-well culture plates.  Peptides 
are conjugated to the monolayers by incubation of click solution and peptide ligand (1:1, 10µL) 
at room temperature for 12 h.  
Cell culture   
Human ADSCs were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) low glucose (1 
g/mL) media supplemented with 10% fetal bovine serum (Invitrogen), 1% penicillin/streptomycin 
(p/s), media changed every 3-4 days and passaged at ~80% confluency using 0.25% 
Trypsin:EDTA (Gibco).  MEFs were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
high glucose (4.5 g/mL) media supplemented with 10% fetal bovine serum (Invitrogen), 1% 
penicillin/streptomycin (p/s)and passaged at ~80% confluency using 0.05% Trypsin:EDTA 
(Gibco).  Passage 4-6 ADSCs and passage 6 MEFs were seeded onto microarrayed and non-
microarrayed surfaces at a cell density ~15,000 cells/cm2 for ADSCs and ~30,000 cells/cm2 for 
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MEFs.  After 1 h incubation at 37ºC and 5% CO2, non-adherent cells were aspirated, surfaces 
were washed, and fresh media added.   
Cell differentiation 
 For long-term differentiation studies, human ADSCs were seeded on non-microarrayed SAM 
surfaces (~10,000 cells/cm2) and cultured in basal media (low glucose DMEM supplemented 
with 1% p/s and 10% FBS) or osteogenic media (low glucose DMEM containing FBS, 
Gentamicin/Amphotericin, L-glutamine, dexamethasone, ascorbate and β-glycerophosphate).  
Media was changed every 3-4 days for 21 days.   
Cell attachment quantification 
Quantification of ADSC and MEF spot coverage in brightfield images was performed using 
ImageJ (NIH).  The “Image Edge” plugin developed by Thomas Boudier (available at 
http://www.snv.jussieu.fr/~wboudier/softs.html) was applied to images of array spots and then a 
threshold was applied to select areas marked by cells.  Circular regions of interest (ROIs) were 
sized to the same dimensions of an array spot and were used to define areas for measurement 
(Fig. S3).  A minimum of 3 subarrays, each containing at least 4 spots per peptide combination, 
were measured. 
Immunohistochemistry   
Cells were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 in 
PBS for 30 min, and blocked with 1% BSA in PBS for 15 min.  Primary antibody labeling was 
performed in 1% BSA in PBS solution overnight at 4ºC with rabbit anti-osteopontin (Abcam, 
1:500 dilution) and mouse anti-Runx2 (Abcam, 1:500 dilution).  Secondary antibody labeling 
was performed similarly in 5% goat serum containing 1% BSA in PBS solution with 
Tetramethylrhodamine-conjugated anti-rabbit IgG antibody and Alexa Fluor 647-conjugated 
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anti-mouse IgG antibody (1:500 dilution) along with Alexa Fluor 488-phalloidin (1:250 dilution) 
and DAPI (1:5000 dilution) for 20 min at 37ºC.   
Microscopy   
Brightfield images were taken with a MOTIC AE31 inverted microscope with a Moticam 3 Digital 
Color Camera.  Immunofluorescent imaging was performed on an IN Cell Analyzer 2000 (GE).  
A minimum of 16 fields of view were taken for each sample condition.  Immunofluorescent 
images were analyzed using ImageJ.  Regions of interest for Runx2 and osteopontin were 
selected by outlining nuclei in the DAPI channel.  Mean integrated density of every cell localized 
to the region of interest was averaged for each replicate.  To normalize fluorescence intensity 
for cells of differing sizes, we chose to only report the average fluorescent intensity localized at 
the nucleus. At least three independent experiments each with triplicate samples were 
performed to verify results.  One-way ANOVA was performed using OriginPro software. 
Infrared spectra (IR) 
IR spectra was collected on a Perkin Elmer 100 serial FTIR spectrophotometer calibrated with 
polystyrene film.    
Mass spectrometry 
Mass analysis was performed using a Bruker UltrafleXtreme time-of-flight (TOF) mass 
spectrometer (Bruker) in positive reflector mode.  1µL of each spotting solution was manually 
pipetted onto a small Au substrate and allowed to sit 30 min. SAM surfaces were rinsed and 
attached to a custom MALDI plate using a small spot of high vacuum grease (Dow Corning).  
1µL of α-Cyano-4-hydroxycinnamic acid (HCCA, Bruker) matrix dissolved in mixture of 1:2 
acetonitrile (ACN): 0.1% Trifluoro acetic acid (TFA) in ultra pure water was spotted to the 
surface of each SAM.  Mass spectra were obtained at 100 µm resolution with each spot 
summed from 200 laser shots.  Mass calibration was done with peptide calibration standard II 
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(Bruker).  Spectra was analyzed with flexAnalysis software (Bruker) and replotted with Origin 
(OriginLab). 
X-ray photoelectron spectroscopy (XPS)   
XPS data were acquired using a Kratos Axis ULTRA Imaging X-ray Photoelectron Spectrometer 
(Kratos Analytical Ltd.) with a monochromatic Al Kα source (1486.6eV).  Spectra was obtained 
in spectroscopy mode with a base pressure below 1x10-8 Torr.  The take-off angle was set to 
90°, and an analyzer slot aperture of 0.3mm x 0.7mm.   Survey spectra were collected from 0 to 
1100 eV with a 1.0eV step size, 100 ms dwell time and an analyzer pass energy of 160 eV.  
High-resolution spectra were obtained for photoelectrons emitted from C 1s, N 1s, and Au 4f 
with a 0.1 eV step size, a dwell time of 100 ms, and analyzer pass energy of 40 eV.  Electron 
binding energies were calibrated with respect to the Au 4f peak at 84.0 eV.  All XPS analysis 
was performed with CasaXPS software.  Analysis of spectra involved background subtraction 
using a Shirley routine and a subsequent fitting of Gaussian-Lorentzian line-curves using a 
Marquardt-Levenberg optimization algorithm.   
Ellipsometry 
Ellipsometric measurements were made with a J.A. Woollam VASE spectroscopic ellipsometer 
with wavelength of 500-800 nm and incident angles of 65, 70, and 75°. Thicknesses were 
computed with a planar two-layer (substrate, monolayer) Cauchy model with refractive index set 
at 1.40 for the monolayer[169].  
Atomic force microscopy (AFM) 
The measurements were carried out with an Asylum Research MFP-3D AFM in non-contact 
(tapping) mode.  AFM scans were performed in air. A rotated, monolithic silicon tip 
(BudgetSensors) was used. 
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4.3  Results and discussion 
Development of peptide derivatized self-assembled monolayers on gold surfaces  
Peptides were synthesized manually using standard Fmoc solid-phase methodology and 
purified via HPLC.  We chose to cap our peptides with an alkyne-containing capping reagent to 
yield a terminal alkyne that is amenable to bioconjugation to an azide terminated surface.  This 
strategy allows us to investigate combinations of peptides by simply mixing stock peptide 
solutions in the desired ratios[170].   
Within each well of a 384-well plate, we mixed together a stock solution of an azido-EG4-
alkanethiol, a peptide or combination of peptides capped with an alkyne reagent, and a buffer 
containing Cu(I), TBTA, and sodium ascorbate to catalyze the cycloaddition reaction.  The plate 
was incubated for one hour at 37ºC before printing.  Using an OmniGrid Microarrayer, the 
microarray tips act as features, depositing small nanoliter scale volumes onto the surface of the 
gold.  Alkanethiols in the spotted solutions adsorb immediately to the gold to form self-
assembled monolayers within the printed circular regions (Figure 4.1).  The substrate is 
subsequently washed and immersed in a background solution of HS-C11-EG3 to render the 
non-spotted regions inert to protein adsorption.   
FTIR was used to monitor the completion of the peptide conjugation to the HS-C11-EG4-N3 in 
solution (Figure 4.2).  After 1h at 37°C we observed that the azide peak at λ 2110 cm-1 
completely disappears, demonstrating fast conjugation of the alkyne-terminated peptide with the 
azide-terminated alkanethiolate.  After spotting the mixture on the gold substrate, XPS was used 
to confirm the presence of a monolayer as well as conjugation of peptides.  The underivatized 
monolayer surface containing 15% HS-C11-EG4-N3 to HS-C11-EG3 shows low atomic % of 
nitrogen species (Figure 4.3a) as expected for the diluted azide monomer. The C1s narrow scan 
of this surface reveals the presence of C-C to C-O peaks in percentages of 65.2% to 34.8% 
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respectively (Figure 4.3b), in close agreement with an expected percentages of 65% to 35%. 
After cycloaddition reaction, surfaces included noticeable increases in the N1s narrow scan 
spectra (Figure 4.3c), as well as the appearance of a C=O peak in the C1s spectra (Figure 
4.3d).   
Mass spectrometry of self-assembled monolayers on gold, a technique termed self-assembled 
monolayer desorption ionization (SAMDI) by Mrksich and co-workers[171], is an effective 
method for characterizing the products from interfacial reactions on SAMs[172].  To 
demonstrate that spotting the reaction solution directly onto a gold slide will enable robust 
monolayer formation, we simulated printing conditions by transferring 1µL of spotting solution 
onto the surface of a cleaned gold surface.  After 30 minutes, this surface was cleaned and 
mounted on a custom plate for matrix assisted laser desorption ionization (MALDI) mass 
spectrometry.  MALDI analysis reveals peaks corresponding to the conjugated peptide-
alkanethiolate species, as well as several disulfide peaks formed either between two conjugated 
peptide-alkanethiolate species, or with the HS-C11-EG3 diluent. For instance, spotted 
KPSSAPTQLN shows a single peptide-alkanethiolate conjugate at m/z 1562.2 as well as the 
disulfide at 3114.2, and another disulfide corresponding to the addition of the EG3-terminated 
background alkanethiolate at 1893.6 (Figure 4.4a).   
To further verify that we are forming SAMs using the microarraying strategy, we performed 
ellipsometry and atomic force microscopy on microarray spots.  The ellipsometric thickness of a 
SAM containing just HS-C11-EG3 was measured to be approximately 1.22 nm.  This thickness 
increased to 1.49 nm for the monolayer surface containing 15% HS-C11-EG4-N3 to HS-C11-
EG3, and 1.66 nm when a peptide (KPSSAPTQLN) was conjugated (Table 4.1).  The thickness 
was calculated assuming a parallel, homogeneous, two-layer (monolayer, substrate) model with 
an assumed refractive index of 1.4 for the organic layer[169]. Our observed thicknesses are 
comparable to those of previously reported SAMs of similar structure[169,173]. AFM 
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measurements at the edge of one of the SAM spots show a height difference of approximately 
1.5nm between the formed SAM and the gold substrate, in good agreement with our 
ellipsometry measurements. 
To assess whether the peptides are homogenously distributed when SAMs are formed, we 
spotted arrays of a peptide containing a lysine residue in proximity to the distal end (FHRRIKA).  
We biotinylated the free amine of the lysine with a sulfo-NHS-Biotin reagent followed by 
incubation in the presence of a Cy3-conjugated streptavidin.  A control array of the peptide was 
incubated with the Cy3-streptavidin without prior biotinylation (Figure 4.4b). We see uniform 
fluorescence across our SAM spots demonstrating that the peptide is evenly distributed.  No 
fluorescence is seen on peptide spots without prior biotinylation, highlighting the ability of the 
SAMs at resisting non-specific protein adsorption[174]. 
Previous work by Chelmowski et al. demonstrated that click chemistry is well suited for the 
production of peptide-based SAMs due to its high selectivity and tolerance for all functional side 
groups in peptides[174].  Furthermore, they showed that performing the click reaction in solution 
is more efficient than conjugation to a pre-formed azide or alkyne-terminated SAM[175]. Our 
strategy provides great flexibility over the peptide or peptide combination presented at each spot 
without the need to generate entire peptide-conjugated alkanethiol molecules.  By forming 
peptide-conjugates in solution, we avoid complications involving steric effects of bulky 
molecules approaching an immobilized organic surface.  In this way, any small molecule or 
ligand containing an alkyne group can be tethered to the microarray surface. 
Cell adhesion and spreading on peptide microarrays 
To optimize our spot size and reproducibility, we experimented with a number of buffer solutions 
and incubation conditions for the generation of well-defined arrays.  We initially found that the 
mixed buffer containing H2O, ethanol, and DMSO evaporated rapidly within 1 minute after 
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spotting, giving poor spot fidelity after cell seeding.  We judged spot fidelity by how well the cells 
adhered and remain localized in circular spots of peptides known to mediate adhesion (YIGSR). 
To improve spot fidelity, we investigated various buffer additives, incubation and cleaning 
methods.  We experimented with a number of additives and found that a small amount of 
glycerol (3%-10%) greatly improved spot fidelity.  Substrate and incubation time also had large 
effects on the microarray spots.  Long incubation times post-spotting generally lead to non-
specific adhesion and spots with low definition, possibly due to spreading of the alkanethiol 
spots.  We observed optimal results with low concentrations of glycerol (3%-10%) with spotted 
surfaces washed immediately (Figure 4.5).  Our trials with various spotting techniques indicate 
the importance of substrate cleanliness in the formation of well-defined spot sizes. Minimal 
exposure to atmospheric conditions as well as minimal disruption to the deposited gold 
improved spot size and homogeneity.  However, long post-spotting incubation times even in 
dessicator and low vacuum conditions appeared to favor breakdown of well-defined microarray 
spots.  This may be related to non-specific spreading of alkanethiols to the intervening 
background regions. 
The synthesis of novel biomimetic materials requires an understanding of the complex 
components of the extracellular matrix (ECM) and their interactions with one another.  In a 
recent review, Hudalla and Murphy highlight strategies wherein growth factors and 
glycosaminoglycans can be incorporated into biomaterials to regulate stem cell behavior[176].  
We used our peptide microarrays to screen cell adhesion characteristics on combinations of an 
adhesion peptide YIGSR[177], a growth factor peptide derived from bone morphogenetic protein 
7 (BMP-7)[44], and a heparan sulfate binding peptide (KRSR) known to promote attachment of 
osteoblasts[178].  We spotted each of these peptides individually as well as in combination and 
examined the adhesion characteristics of human adipose derived stem cells (ADSCs) as well as 
mouse embryonic fibroblasts (MEFs) after 3 days in culture.  Cells displayed differential 
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adhesion characteristics depending on the peptide ligands they were seeded on and remained 
confined in spots for over 10 days in culture.  We quantified “% surface coverage” within each 
spot, where surface coverage is defined by the fraction of the spot occupied by a given cell type.  
For ADSCs we see similar levels of surface coverage on YIGSR and KRSR surfaces, as well as 
on all combinations (Figure 4.5a, 4.5c).  Interestingly, KPSS surfaces, which have been shown 
to enhance osteoblast spreading[44], had low levels of adhesion of ADSCs, while KRSR, also 
shown to promote osteoblast attachment[178], had high levels of ADSC coverage.  Even though 
both peptides may promote adhesion of osteoblasts, the difference in spreading of ADSCs may 
suggest that they bind to osteoblasts via different mechanisms.  For MEFs we observed 
relatively high coverage on KPSS peptides, and very low adherence to KRSR peptide (Figure 
4.5b).  The combination of YIGSR and KPSS displayed the highest surface coverage, while a 
combination of KPSS and KRSR displayed significantly lower coverage (~50% of coverage on 
KPSS).  The combination of all three peptides had coverage similar to just KPSS.  We reason 
that these differences in surface coverage are due to approximately one-half and one-third of 
the surface occupied by the KRSR peptide respectively, which does not support fibroblast 
adhesion[178].  This is in contrast to ADSCs, in which KRSR peptide and combinations 
containing this peptide show high surface coverage.  Also unlike ADSCs, MEFs seem to much 
more readily adhere to surfaces presenting the BMP7 peptide.  Importantly, we spotted a 
scrambled peptide GRDGS that showed no cell adhesion for either cell types (Figure 4.5), 
indicating that adhesion characteristics are based on the defined peptide ligand rather than non-
specific protein adsorption.  These results demonstrate that this microarray platform can be a 
useful tool to screen the adhesion properties of various cell types to different peptide ligands.  
The contrasting spreading properties of ADSCs and MEFs on KPSS and KRSR peptides 
suggest that these peptides bind to different cellular receptors that are differentially regulated 
between these cell types. 
69 
 
ADSC differentiation on combinatorial peptide surfaces 
BMP-7 has been successfully tested in animal models and clinical trials for bone fusion and 
regeneration[179,180].  We hypothesized that a surface presenting a BMP-7 derived peptide 
may preferentially promote multipotent ADSCs to differentiate into bone.  Since we determined 
based on our microarray assay that KPSS only weakly supports ADSC adhesion, we chose to 
examine cell adhesion peptides GRGDS[165] and YIGSR, and their combination with BMP-7 
peptide KPSS.  To assess differences in differentiation for ADSCs cultured on these various 
peptide combinations for extended times, we cultured cells on ~1 cm2 peptide conjugated 
surfaces for 21 days in basal and osteogenic media.  Cells were subsequently fixed and stained 
for runt-related transcription factor 2 (Runx2) (Figure 4.6a), a master transcription factor 
associated with osteogenic differentiation, and osteopontin (OPN) (Figure 4.6b), a later stage 
osteogenic marker.  We observed low levels of adhesion on KPSS peptide surfaces, in 
agreement with our microarray screen.  However in basal media conditions, adherent cells on 
these surfaces had significantly higher intensity of Runx2 (Figure 4.6c) and OPN (Figure 6d) 
compared to the adhesion peptides GRGDS and YIGSR.  Combinations of GRGDS with KPSS 
and YIGSR with KPSS also had significantly higher expression of Runx2 and OPN than the 
adhesion peptide alone.  In osteogenic media, we observed no significant differences in either 
Runx2 (Figure 4.6e) or OPN (Figure 4.6f) on these various peptide surfaces.  Classically, 
osteogenic differentiation in vitro is performed using supplemented media containing a milieu of 
pro-osteogenic factors, especially dexamethasone, beta-glycerophosphate, ascorbic acid, and 
other growth factors[181].  We hypothesize that the effects of these factors in the osteogenic 
media condition abrogated any differences that the peptide surfaces may have had on cultured 
cells.   
BMP-7 has been shown to upregulate Runx2 and promote an osteogenic phenotype in 
precursor cells[182,183].  A study by Knippenberg et al. using BMP-2 and BMP-7 and adipose 
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derived stem cells found BMP-7 actually downregulated osteogenesis and stimulated a 
chondrogenic phenotype[184].  However, the role of BMP-7 in promoting both chondrogenesis 
and osteogenesis is documented and is dependent upon cell, media, and culture 
conditions[185].  Using biomimetic peptides rather than entire bone morphogenetic proteins may 
provide a more controlled condition to investigate ligand effects on cell fate since proteins may 
have multiple competing interaction sites as well as tertiary structures.  We observed elevated 
levels of Runx2 and OPN expression on BMP-7 derived KPSS peptide alone and in combination 
with fibronectin and laminin derived adhesion peptides GRGDS and YIGSR (Figure 4.6c,d).  
This result is similar to that of Zouani et al., who grafted RGD peptides on poly(ethylene 
terephthalate) with biomimetic peptides derived from the knuckle epitope of BMP-2,7, and 9 and 
saw upregulation of Runx2 and production of extracellular matrix[186].  He and colleagues 
reported similar results using a BMP-2 derived peptide in conjunction with RGD on a hydrogel 
substrate[187].  Biomaterials and drug delivery systems incorporating BMPs appear to be a 
promising way to improve bone formation while reducing costs of large-scale production of 
recombinant BMPs[188,189].  Limitations to these materials involve determining optimal density 
of peptides, as well as preventing non-specific adsorption of proteins[188].  Our self-assembled 
monolayer based microarray platform allows us to address both these issues.  This approach 
allows us to investigate the specific effects of ligand combinations, while giving us flexibility to 
easily tune ligand density ratios and compositions.  For instance, Kilian and Mrksich 
investigated the effect of ligand density on mesenchymal stromal cells.  They reported that high 
affinity ligand promoted osteogenic fate decisions, while low affinity ligands could promote either 
muscle or neural differentiation based on ligand density[110].   Rezania and Healy also 
examined the importance of ligand density by demonstrating that adhesion and differentiation 
on mixed peptide surfaces are dependent on cell type as well as the ratio of peptide ligands.  
They investigated an RGD peptide with a heparin-binding peptide FHRRIKA in 25:75, 50:50, 
and 75:25 ratios and found a 50:50 or 75:25 ratio of RGD to FHRRIKA promoted greater 
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spreading and mineralization for RCO cells[190].  The importance of peptide ligand density 
when presented in combination has been further illuminated by Murphy and colleagues who 
demonstrated that growth factor binding peptides can be agonists or antagonists depending on 
the density of presentation[191].  With the platform presented here, researchers may tune ligand 
affinity and density, as well as investigating effects of combinations of ligands in different ratios. 
4.4 Conclusion 
Our results demonstrate a simple procedure to form peptide microarrays in a single-step using 
the robust azide-alkyne cycloaddition reaction. Cells seeded onto the spotted regions remain 
localized for over a week, allowing for the use of this method for long-term culture experiments.  
We demonstrated the utility of this platform for cell biology investigations by exploring a 
combination of an adhesion peptide and BMP-7 derived peptide combination and found that the 
presence of the BMP-7 peptide promoted the expression of osteogenic markers Runx2 and 
OPN.  We anticipate this technique will be useful in the future for screening many different 
growth factor and adhesion peptides, at variable densities and in combination, for a variety of 
cell types. 
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4.5 Tables and Figures 
 
 
 
 
 
 
 
Figure 4.1 Scheme for spotting of microarray surfaces.  A background EG3-terminating alkanethiol is mixed with 
an azide-terminating alkanethiol and an alkyne terminated peptide along with CuBr and TBTA in 384-well plates 
(1,2).  This solution is incubated for 1h and then spotted onto a gold surface using an OmniGrid microarrayer to 
form defined regions of specific peptides (3).  After washing, the microarray chip is immersed in a solution of 
background EG3 alkanethiol (4) to passivate the non-spotted regions. 
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Figure 4.2 Conjugation of alkyne-terminated peptide KPSSAPTQLN to azide-terminated SAM assessed in 
solution via FTIR.  A control solution of HS-C11-EG4-N3 dissolved in H2O: ethanol: DMSO at concentration 
40mM (solid black line) shows clear azide peak at 2110 cm-1.  Control peptide in H2O at concentration 40mM 
(solid red line) and conjugate after 1 hour (solid blue line) demonstrate disappearance of azide groups (λ = 2110 
cm-1). Reactions were performed under the same microarray printing experimental conditions. 
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Figure 4.3 XPS data for azide-terminating surfaces and peptide-conjugated surfaces: N1s narrow scan of 
surfaces before (a) and after (c) peptide conjugation; C1s narrow scan of surfaces before (b) and after (d) peptide 
conjugation. 
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Figure 4.4 Characteristic SAMDI spectra for peptide KPSSAPTQLN.  We generally observed up to three peaks 
for each peptide conjugated SAM (a).  Species i corresponds to the conjugated peptide species, while species ii 
and iii represent the disulfides formed with either the HS-C11-EG3 background, or two peptide conjugated 
alkanethiolates respectively.  Spotted regions of a peptide (FHRRIKA) containing a lysine adjacent to the distal 
end of the SAM (b) is biotinylated with a Biotin-NHS reagent.  After incubation in the presence of Streptavidin-Cy3 
(SA) for 30 min. at room temperature, we see uniform fluorescence across the peptide spots.  Non-biotinylated 
spotted regions incubated with SA show no fluorescence. 
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Figure 4.5 Brightfield images and quantification of % surface coverage of ADSC (a) and MEF (b) on various 
peptide spots.  Scale bar = 200µm. *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001 by one-way ANOVA. 
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Figure 4.6 Immunofluorescent images of ADSCs cultured 3 weeks on peptide combinations. Green = actin, Blue 
= nuclei Red= Runx2 (a) or OPN(b).  Scale bar = 200µm.  In basal media, quantification of Runx2 mean intensity 
(c) and OPN mean intensity (d) between the peptide surfaces.   (*) denotes significant difference between groups 
(p < 0.05).  In osteogenic media, Runx2 (e) and OPN(f) were not significant. 
 
78 
 
Table 4.1 Ellipsometric measurements of SAM thicknesses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surface Thickness (nm) 
HS-C11-EG3 1.22 ± 0.21 
HS-C11-EG4-N3 1.49 ± 0.21 
Peptide 1.66 ± 0.21 
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CHAPTER 5 
PEPTIDE MICROARRAYS FOR THE DISCOVERY OF CELL-LIGAND INTERACTIONS THAT 
PROMOTE A CANCER STEM CELL PHENOTYPE IN MELANOMA CELL CULTURE4 
5.1  Introduction 
Cutaneous melanoma is the most deadly form of skin cancer, with poor prognosis in patients 
with distant or recurring metastases[192]. Recent exploration into the pathogenesis of 
melanoma metastasis has revealed that a small subpopulation of tumor-initiating cells, 
postulated to be cancer stem cells (CSCs), correspond to increased metastatic 
progression[193].  Like traditional stem cells, these CSCs are thought to be highly proliferative, 
self-renew, and have the capabilities of reconstituting the entire tumor environment[194].  The 
cancer stem cell hypothesis helps explain the perplexing and poorly understood clinical 
phenomena where a patient with cancer may have robust response to chemotherapy treatment 
only to have eventual relapse[195].  As such, studies aimed at classifying CSCs could provide 
new insights into disease progression, and assist in the identification of this dangerous 
subpopulation of cells for therapeutic targeting. 
Several recent high profile studies have presented evidence that tumor-initiating melanoma cells 
are much more common than previously appreciated, and that no single surface marker can 
distinguish between a tumorigenic and non-tumorigenic phenotype[196,197]. Although these 
disparate results seem to challenge the classical cancer stem cell model in which only a subset 
of cells are capable of tumor formation, this model is not mutually exclusive with a more 
traditional stochastic model that postulates that all tumor cells are capable of tumor formation 
and progression[198]. Furthermore, factors such as environmental cues can facilitate a 
 
4This chapter has is adapted from the following publication:   
Douglas Zhang and Kristopher A. Kilian, Peptide microarrays for the discovery of cell-ligand interactions that promote a cancer stem 
cell phenotype in melanoma cell culture, In preparation. 
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phenotypic change between cancer and non-cancer stem cells[199,200]. In fact, increasing 
efforts to elucidate the role of the microenvironment on the progression of cancer has identified 
elements of the tumor microenvironment as important prognostic and predictive indicators of 
metastasis[201,202].  These elements include perivascular cells and the cytokine and growth 
factor network they secrete[203], integrins[204], the extracellular matrix protein 
composition[205] and surrounding stroma[206], as well as the mechanical properties of the 
stroma[201].  Taken together, these studies suggest that when thinking about cancer stem cells, 
we should also consider the biophysical and biochemical characteristics of the tumor 
microenvironment in which they reside.  
To explore how microenvironment parameters can influence CSC characteristics, high 
throughput approaches have been developed to screen for materials properties that guide cell 
state and fate determination.  Typically, high-throughput approaches to model microenvironment 
have largely focused on characterizing cell response to the adhesive properties of the 
substrates.  Early work by Langer et al. exploited the use of robotic fluid handling to create 
arrays of polyacrylate monomers to study the effect of polymer-stem cell interactions[23]. Lutolf 
et al. used a DNA spotter to create cell niches microarray spots with modular stiffness (1-50kPa) 
per well, along with various combinations of proteins to study proliferation, quiescence, and 
death of neural stem cells[56].  Kiessling and coworkers applied SAMs on gold into an array 
type format investigating the effects of various peptide ligands on stem cell culture[46]  and 
embryonal carcinoma cell binding capabilities[49]. Recently these high-throughput screening 
techniques have enhanced our understanding of cancer cell adhesion-mediated signaling[207], 
specifically the role of the extracellular matrix (ECM). Bhatia et al. used an array of ECM 
proteins to screen the adhesion profiles of primary and metastatic tumor cells and found that 
metastatic cells selectively associate with certain combinations of ECM molecules[208]. Peyton 
et al. combined ECM proteins to mimic the in vivo characteristics of bone, brain, and lung, and 
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created a cellular phenotypic fingerprint of bone, brain, and lung metastasis that could predict 
metastatic tropism of other heterogeneous cell lines[209]. Furthermore, work by Hendrix et al. 
using ECM matrices secreted by human embryonic stem cells (hESC) demonstrated that 
exposure of melanoma cells to the hESC microenvironment was sufficient to reprogram the 
melanoma cells to a more native state[210]. These studies suggest that the biophysical 
interactions between cancer cells and the matrix are key mediators of transdifferentiation and 
phenotype switching[211]. We hypothesize that by using small peptides that constantly engage 
cell surface receptors, we can promote a similar response in melanoma cell reprogramming. 
 In this chapter we use a single-step peptide microarray chemistry[124] to explore the 
combinatorial presentation of short peptides that engage different classes of cell surface 
receptors in adherent melanoma cells. We demonstrate that this array approach is able to 
identify unique peptide combinations that promote expression of CSC markers. Concurrent 
interaction with an adhesion and growth factor derived sequence reveals a role for each peptide 
in modulating the melanoma cell state, and identifies Smad 2/3 as a key signaling pathway in 
which these markers are upregulated. Functional studies suggest these cells adapt a CSC-like 
phenotype; however, this phenotype is transient and the cells will revert when returned to 
standard cell culture conditions. This approach provides a tool for exploring how cancer cells 
integrate multiple matrix signals to regulate metastatic potential, and may prove useful as a 
platform for the development of drugs that target metastatic and tumorigenic cell populations. 
5.2 Materials and methods  
Materials 
General laboratory chemicals and reagents were purchased from Sigma-Aldrich and Fisher 
Scientific unless otherwise specified. Peptide synthesis resin and amino acids were purchased 
from Anaspec. 11-(2-{2-[2-(2-azido-ethoxy)-ethoxy]-ethoxy}-ethoxy)-undecane-1-thiol (referred 
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to herein as HS-C11-EG4-N3) was purchased from Prochimia (Sopot, Poland, TH 008-m11.n4-
0.2).  Triethylene glycol mono-11-mercaptoundecyl ether (referred to herein as HS-C11-EG3) 
was purchased from Sigma Aldrich (673110). Glass coverslips were purchased from Fisher 
Scientific. Cell culture plasticware was purchased from Denville Scientific. Cell culture media, 
fetal bovine serum (FBS), and penicillin/streptomycin (P/S) were purchased from Corning.  
Cell source and culture 
The B16F0 murine melanoma cell line was obtained from American Type Culture Collection. 
B16F0s were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose (4.5g/mL) 
media supplemented with 10% FBS and P/S, media changed every 3 days, and passaged at 
~90% confluency every week using 0.05% Trypsin. B16 cells were tested for mycoplasma 
contamination at Charles River Laboratories for cell line testing prior to in vivo experiments. 
Peptide synthesis 
Peptides were synthesized manually by standard Fmoc solid-phase methodology as previously 
described in chapter 4[124]. Briefly, N-terminal fluorenylmethyloxycarbonyl (Fmoc) protected 
rink amide resin was deprotected with 20% piperidine in N’,N’-dimethylformamide (DMF) for 15 
min. The solvent was filtered and the resin was washed 4 times with DMF. A solution containing 
3 equivalents of amino acid, benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate (PyBOP), and N-methylmorpholine in DMF was then added and incubated 
at room temperature for 1 hour with gentle rocking. After coupling, the resulting solution was 
filtered, the resin was washed 4 times with DMF, and the next Fmoc was deprotected. Coupling 
and deprotection was assessed using a ninhydrin test. After all amino acids were coupled, the 
peptides were capped with a propargyl-PEG-NHS ester (Quanta Biodesign, 10511) in DMF 
overnight. The resin was cleaved with a cocktail containing 95% trifluoroacetic acid (TFA), 2.5% 
H2O, and 2.5% triisopropylsilane (TIS) for 3h and the peptides were filtered from the resin. The 
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peptide was precipitated by adding ice-cold diethyl ether and after 3 dissolve/precipitate steps 
using TFA/ether, finally dissolved in water and lyophilized. Final products were analyzed with 
low resolution electrospray ionization (ESI) (Waters Quattro II) and semipreparative reversed-
phase high-performance liquid chromatography (RP-HPLC) (Perkin-Elmer Flexar).  All peptides 
used were purified to >90% purity as assessed by HPLC, dissolved in deionized H2O, and 
stored at -20ºC. Bioactive peptides synthesized are listed in Supplemental Figure X. 
Gold surface preparation  
5 nm of Cr followed by 20 nm of Au were deposited onto the surface of cleaned glass coverslips 
(60 x 24 x 0.1mm dimensions). Gold coverslips were stored in a dessicator for up to two weeks 
before use. Prior to use, gold substrates were cleaned by briefly sonicating for 1 min. in glacial 
acetic acid followed by 1 min. in ethanol. Gold coverslips were cut to approximate size 24 x 
24mm using a diamond indenter and mounted onto 75 x 25mm microscope slides by applying a 
thin layer of ethanol to the interface.  
Peptide microarray formation 
A panel of 12 peptides were used, in single and as a combination with the other 11 peptides, for 
a total of 78 peptide combinations. Peptide Microarrays were printed as previously 
described[124]. Stock solutions of peptide ligand (1mM in H2O), Tris[(1-benzyl-1H-1,2,3-triazol-
4-yl)methyl]amine (TBTA) (5mM in DMSO/t-butyl alcohol (3:1)), and HS-C11-EG4-N3/HS-C11-
EG3 (15% azide mol fraction in ethanol) solution were prepared. Click solution was prepared by 
combining TBTA solution with copper (10mM CuBr, 10mM sodium ascorbate in DMSO) solution 
(2:1 v/v).  Peptide combinations (5µL total), click solution (5µL), and HS-C11-EG4-N3 solution 
(10µL) were pipetted to a 384-well plate and incubated 1 hour at room temperature with gentle 
rocking. A Gene Machines OGR-03 OmniGrid Microarrayer was used to print the solutions of 
the resulting plate in subarray format on the gold-coated surfaces. Each peptide combination 
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was printed as a column of 6 replicate spots. The substrate was removed from the microscope 
slide and thoroughly rinsed with deionized H2O followed by ethanol 4 times. After rinsing, printed 
substrates were immersed in a 0.1% Ethylenediaminetetraacetic acid (EDTA) solution for 20 
minutes, followed by another 4 rinse steps of H2O/ethanol. Substrates were then immersed in a 
HS-C11-EG3 solution to render the non-printed regions inert to nonspecific adsorption. In 
addition to the 78 peptide combinations, 3 negative controls (RDG, PBS, and HS-C11-EG4-N3) 
and 3 positive controls (GRGDS, YIGSR, IKVAV) were printed on each slide, giving 84 x 6 
replicate spots = 504 total spots for each 25 x 25 mm coverslip. Printed peptide microarray 
substrates were transferred to 6-well plates and seeded with B16F0 cells at a concentration of 
~80,000 cells/mL. After 24 hours, microarray chips were transferred to new 6-well plates to 
prevent migration of cells attached to perimeter of the wells. Chips were cultured for an 
additional 4 days, with media change every 2 days.  
Non-patterned self-assembled monolayers  
For investigations of specific peptides outside the array, Au surfaces were immersed in 15% 
HS-C11-EG4-N3/HS-C11-EG3 overnight to form monolayers. Surfaces were rinsed with 
ethanol, dried with air, and cut to fit into 24-well or 6-well culture plates. Peptides were 
conjugated by incubating the monolayer surface to a 1:1 solution of click solution and peptide 
ligand solution for 12 hours at room temperature. 
Immunofluorescence 
Cells were fixed with 4% paraformaldehyde for 20 min., followed by permeabilization with 0.1% 
Triton X-100 in PBS for 20 min., and blocked with 0.1% bovine serum albumin in PBS for 30 
min. Primary antibody labeling was performed in 0.1% BSA solution overnight at 4ºC. 
Secondary antibody labeling was performed similarly in 2% goat serum, 1% bovine serum 
albumin PBS solution for 1 hour at room temperature. Samples were mounted using ProLong 
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diamond antifade mountant (Thermo Fisher) and immunofluorescence microscopy was 
performed using an IN Cell Analyzer 2000 (GE) microscope. For peptide microarray surfaces, 
the entire area was imaged at 10x magnification and stitched together using ImageJ software. 
To quantify marker expression, a region of interest was drawn around each peptide spot 
(approximately 100µm in diameter) and a threshold was set to determine positive signal. The 
total integrated density of signal (mean signal x area) of each spot was normalized to the 
number of cells in each spot to generate a signal intensity for each peptide spot. Since there 
was often poor segmentation of nuclei due to high confluency of cells in each spot, we used 
total nuclear area to normalize. For every antibody marker, a minimum of 3 array surfaces each 
containing 6 replicate spots was used.  
Flow cytometry  
B16F0 cells cultured on 24 x 24mm peptide-conjugated self-assembled monolayer substrates 
were detached with 0.05% Trypsin and centrifuged. The resulting cell pellet was fixed in 4% 
paraformaldehyde for 20 min. and permealized in 0.1% Triton X-100 in PBS for 20 min. Cells 
were blocked with 0.1% BSA in PBS for 30 min. and stained with primary antibody in 0.1% BSA 
in PBS overnight at 4ºC. Secondary staining was performed in 2% goat serum, 1% BSA in PBS 
for 1 hour at room temperature. Flow cytometry was performed with a BD LSR Fortessa Flow 
Cytometry Analyzer. Cells stained with secondary antibody but without primary antibodies were 
used as negative controls for gating.    
Western blotting  
B16F0 cells cultured on 24 x 24mm substrates were lysed with RIPA buffer containing protease 
inhibitors (santa cruz) according to manufacturer instructions. A BCA assay kit (Thermo Fisher) 
was used to normalize total protein between samples. 20µg whole cell lysate was resuspended 
in Laemmli buffer and boiled for 5 minutes before running on a PAGEr 4-20% Tris-Glycine gel 
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(Lonza) with Tris running buffer. The gel was blotted to a PVDF membrane using a semidry 
transfer system and blocked with 5% skim milk in TBST for 30 min. Membranes were exposed 
to primary antibody in 5% skim milk in TBST overnight on ice, washed 3 times with TBST, and 
incubated with goat anti-rabbit secondary antibody HRP conjugate (Thermo Fisher) for 1 hour at 
room temperature. After washing the membranes 3 times with TBST, signal is visualized using 
SuperSignal West Pico Chemiluminescent substrate (Thermo Fisher).        
Heparin inhibition assay  
Heparin salt (Sigma H3149) was dissolved in deionized water, filtered through a 0.2µm filter, 
and used at a final concentration of ~12µg/mL. B16F0 cells were pre-cultured with heparin for 
20 min. at 37ºC before centrifuging and washing. Cells were then seeded onto peptided-
conjugated SAMs at a density ~1,000 cells/mL. After 24 hours, surfaces were fixed with PFA, 
permeabilized, and stained with DAPI and Phalloidin.    
Pharmacological inhibition  
MAP kinase inhibitors for ERK1/2 (FR180204), JNK (SP600125), and p38 (SB202190) were 
added to the media at 6µM concentrations during initial seeding and every subsequent media 
change. LDN-193189 was used at a concentration of 30 nM. MG132 was pre-incubated with 
suspended B16F0 cells at a 1 µM concentration for one hour, then removed prior to seeding. 
After 24 hours, MG132 was added to the media at 0.5 µM concentration. 
Wound healing assay   
B16F0 cells were cultured on peptide SAM substrates for five days before trypsinizing and re-
plating on to glass substrates (106 cells per glass coverslip). On the coverslips cells were 
cultured for 12 hours and allowed to grow to about 90% confluence. Three linear scratches were 
made to each coverslip using a pipet tip. Cells were allowed to migrate over a period of 
12 hours, and were observed under brightfield microscopy. Brightfield images of each scratch 
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were taken at initial time and after 12 hours. The total scratch area for each time point was 
determined by tracing the outline of the cells using ImageJ, and wound healing was 
quantitatively assessed by subtracting the final scratch area from the initial scratch area.  
Boyden chamber invasion assay 
Invasion of B16F0 cells through matrigel was assessed using 24-well Boyden chambers 
(Corning) with 8 μm pore inserts. Chambers were precoated with a mixture of Cultrex® Reduced 
Growth Factor Basement Membrane Extract (Trevigen) and cell media to form a final 
concentration of 4mg/mL of basement membrane. Cells were cultured for five days on peptide 
SAM substrates and then tripsinized and re-seeded in serum-free media into the upper 
chambers of each well.  The lower chamber contained serum-containing media and provides 
the chemotactic gradient to drive migration. Cells were cultured for 12 hours before fixing with 
4% paraformaldeyde. Cells on the upper surface of the membrane filter were removed and only 
cells that crossed the inserts to the lower surface were stained with DAPI. Cells on the lower 
surface were imaged using the IN Cell 2000 and counted.  
B16F0 melanoma in vivo model 
Six–eight-week-old female C57BL/6 mice were purchased from Charles River Laboratories for 
in vivo studies. B16F0 cells were cultured on peptide SAM substrates for 5 days before 
trypsinizing and resuspending in Hank’s Balanced Salt Solution (HBSS) buffer. Primary 
localized tumours were established by subcutaneously injecting B16F0 cells (total cell numbers 
1×105, 1×104, 1×103) into the right lateral flank. Six mice were used for each condition. 
Macroscopic tumour growth was serially measured (maximal length and width) with callipers 
three times a week. Tumour growth was checked every three days and experiments were 
stopped when the first mouse of the respective series had a tumour exceeding 2,000 mm3. The 
volume of tumour was calculated using V = (L × W2)/2, where L is length and W is width. Criteria 
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used for primary tumorigenesis was the formation of subcutaneous tumours which were 
detectable by visual examination and measurable with callipers. For comparison of primary 
tumour formation kinetics, mice were evaluated daily until primary tumours exceeded 20 mm in 
diameter, then humanely euthanized. Experimental metastases were established by injecting 
1×105 B16F0 (grown on peptide SAM substrates) melanoma cells via lateral tail vein injection. 
The primary endpoint was survival time, and mice were monitored daily until reaching criteria for 
humane euthanasia. Inoculation of mice with melanoma cells grown on different conditions 
(peptide substrates) and different cell densities was not performed in a random fashion. Rather, 
cohorts of mice were predetermined to receive injections of melanoma cells grown under 
specified conditions and cell densities before inoculation. No blinding was done for these 
animal studies. All experiments using live animals were in compliance with animal welfare 
ethical regulations and approved by the Institute Animal Care and Use Committee 
before experimentation. 
Statistical analysis 
Data from three independent experiments were compared and expressed as mean ± standard 
error of the mean (s.e.m) unless otherwise specified. Statistical tests were performed in 
OriginPro using Student’s t-test for comparisons between two groups, and one-way analysis of 
variance (ANOVA) with Tukey HSD Post-hoc analysis for multiple comparisons.        
5.3  Results and discussion 
Biomimetic peptides and array fabrication  
The extracellular microenvironment during melanoma progression is host to a rich combination 
of molecules that support cell adhesion, proliferation, migration, and differentiation amongst 
other activities[6,212]. We surveyed the literature to identify short oligomeric peptides between 3 
and 12 amino acids in length that were reported to have bioactive 
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properties[44,165,178,190,213–217]. We focused our search on three groups: integrin binding, 
proteoglycan binding, and growth factor derived peptides. Integrins are one of the most studied 
groups of signaling molecules and are known to play a key role in cellular adhesion as well as 
regulating cytoskeletal organization and transmembrane signal transduction[10]. Proteoglycans, 
especially heparin, are able to bind to many different classes of proteins ranging from growth 
factors, to cytokines, to metabolic enzymes and other structural proteins,[6] which highlights the 
importance of proteoglycans in signal regulation. Integrins and proteoglycans often act 
synergistically with other growth factor receptors[3] to regulate cell function and behavior[11]. 
We selected a subset of 12 peptides which were derived from major extracellular matrix proteins 
and growth factors (Table 5.1). We chose to investigate these 12 peptides individually and 
pairwise with each other (78 total combinations).  
To investigate cell-ligand interactions on these peptides, we expanded and optimized our array 
spotting platform[124] to print circular islands of peptide-conjugated alkanethiolates (Figure 
5.1a) onto gold coated coverslips. Each island contains either a single or pairwise peptide 
combination. We used coverslips approximately 25mm x 25mm, each containing 6 replicates of 
the 78 peptide combinations, 3 negative controls, and 3 positive controls, arranged into 
subarrays, for a total of 504 spots per coverslip (Figure 5.1b). Each spot is spaced 150 µm 
apart, and each subarray is spaced 1000 µm apart to easily differentiate between subarrays. To 
fabricate the arrays, we created a master 384-well plate by pipetting peptide(s), a 15/85 mol/mol 
solution HS-C11-EG4-N3/HS-C11-EG3, and a click solution containing Cu(I), TBTA, and 
sodium ascorbate into each well of the plate. The plate was gently rocked at room temperature 
for 1 hour before spotting. An OmniGrid Microarrayer was then used to transfer nanoliter scale 
volumes of solution from the well plate onto the surface of the gold coverslips. After rinsing, the 
substrate was immersed overnight in a solution of HS-C11-EG3 to pegylate the non-spotted 
regions and prevent non-specific background adsorption. Since only nanoliters of solution are 
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deposited during each print step, we were able to parafilm the master plates and store them at -
20ºC. We found that the master plate could be re-used months later with excellent 
reproducibility in terms of cell adhesion on the various peptides.  
We stored the printed coverslips in 6-well plates and seeded B16 F0 cells onto the substrates in 
normal serum-containing media at a concentration of 80,000 cells/mL. We found a 
concentration between 50,000 and 100,000 cells/mL was optimal for filling in all the spots 
without the cells becoming too confluent at the end of 5 days of culture. After seeding, the plate 
is gently shaken for a few minutes and then stored at 37ºC for 24 hours. The next day we 
transferred the coverslips to a new 6-well plate. By doing so, we prevent cells that attach to the 
non-coverslip areas from growing confluent and expanding onto the printed array. After 5 days 
in culture, array coverslips were removed from media and fixed and stained for quantification. 
For every experiment, 3-6 replicates were printed; within each replicate array, columns 
represent repeat spots of each peptide combination (Figure 5.1b). Between replicates we see 
consistent differential adhesion of B16 melanoma cells to the peptide combinations, with some 
combinations promoting confluent spreading within each spot, and other peptides obstructing 
adhesion (Figure 5.1b insert).  
Peptide arrays for high content quantification of cancer cell markers 
To quantify immunofluorescence staining, the stained array coverslips were mounted with 
ProLong Diamond Antifade facedown onto glass slides and then imaged with a GE InCell 2000 
high content imaging microscope at 10x magnification. 144 images were taken of each 
substrate and stitched together in ImageJ to show the entire slide (Figure 5.1b).  To quantify 
cells bound to each peptide, regions of interest were drawn around each spot. Within each 
region of interest, the number of cells were counted by creating a mask of the DAPI channel. A 
profile of which peptide combinations support the most adhesion can be built by averaging the 
number of cells adhering to each spot. These adhesion profiles were highly reproducible 
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between replicate slides as well as replicate experiments (Figure 5.2). Marker expression was 
quantified by measuring the integrated density (mean intensity x area) of the thresholded 
positive fluorescence (Figure 5.3). Each spot was then given an intensity score equal to the 
integrated density divided by the total area of the nuclei. These intensity scores were then 
averaged to give us a qualitative assessment of marker expression between various peptides. 
We found that for spots with high confluency, stacking nuclei or nuclei in close proximity often 
resulted in undercounting of cells when we performed automatic segmentation. However, by 
measuring nuclear area and dividing by the average nuclear size, we were able to obtain 
nuclear counts for both high and low confluency spots that agreed well with manual nuclear 
counts (Figure 5.4). We also compared the marker expression intensity scores with the 
adhesion profile to see if higher marker expression was simply an artifact due to more cells 
being present. For eight of our nine markers examined, we saw little to no correlation (R2 < 0.1) 
between marker expression intensity and adhesion.  
As a model system to investigate how materials can influence metastasis and tumorigenicity, we 
used murine B16 F0 melanoma cell lines and examined a variety of traditional stem cell markers 
such as OCT4, as well as putative CSC markers such as ABCB5 and CD271 (Figure 5.5a). 
ABCB5[218], CD271[219], and Jarid1b[220] are putative melanoma cancer stem cell markers. 
Oct4, Nanog, and Sox2 are general “stemness” markers of embryonic stem cells but aberrant 
expression have been associated with cancer stem cell phenotype[221,222]. We focused on 
ABCB5 and CD271 and looked at the correlations between our panels of markers and these two 
well-documented melanoma CSC markers[223]. We observed a high correlation (R2 = 0.70) 
between ABCB5 and CD271 (Figure 5.5b). We also see small positive correlation between 
these two markers and Jarid1b, Stat3, and acetylated lysine (Figure 5.6). These are markers 
which we have previously shown can be upregulated via material cues, and which promoted 
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greater tumorigenicity in mice[224]. Our findings seem to suggest that certain combinations of 
peptides are able to promote upgregulation of these cancer stem cell markers.  
From repeated experiments, we averaged the expression of these two markers (ABCB5, 
CD271) across all peptides.  We focus on a unique peptide combination KRSR+KPSSAPTQLN 
(KRSR+KPSS) which consistently displays high levels of these cancer stem cell markers as well 
as general stem cell markers (Figure 5.5a, 5.5b). KRSR is a heparin sulfate binding peptide 
known to promote attachment of osteoblasts[178] while the KPSS peptide was first identified as 
a bioactive domain of bone morphogenetic protein-7 (BMP-7) and shown to promote 
osteoblastic adhesion and morphology[44].  The presence of this KPSS peptide in promoting 
CSC marker expression is interesting since BMP-7 has been shown to be implicated in 
melanoma tumor progression[225].  We cultured B16 cells on bulk SAM surfaces displaying 
RGD, RGD+KPSS, KRSR, and KRSR+KPSS peptides and performed flow cytometry after 5 
days.  Similar to our immunofluorescent results from our peptide arrays, we see similar elevated 
levels of stem cell and tumorigenicity markers from cells cultured on KRSR+KPSS surfaces 
compared to those on control peptide surfaces. The KRSR+KPSS peptide combination 
displayed significantly higher expression levels of ABCB5, CD271, Jarid1b, and Stat3 compared 
to the RGD control peptide as well as just the KRSR peptide itself (Figure 5.5c). Interestingly, 
when we combine RGD with KPSS, we don’t see higher expression of these markers, 
suggesting that this is a synergistic effect between KRSR and KPSS. 
KRSR mediates melanoma cell adhesion through proteoglycans  
KRSR was first reported by Dee et al. as an adhesive peptide for osteoblast cells that promotes 
binding via a proteoglycan-mediated mechanism[178]. Subsequent studies using this peptide 
have mostly focused on osteoblasts, though we find that the KRSR peptide promotes adhesion 
of melanoma cells comparable to the RGD peptide (Figure 5.7a). We blocked the B16 cell 
membrane receptors by pre-incubating cells with soluble heparin at a concentration of 12µg/mL 
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and see a 60% reduction in cell density after 24 hours on gold substrates presenting the KRSR 
peptide, and a 85% reduction on substrates presenting the KRSR+KPSS peptides (Figure 5.7a, 
5.7b). There were also small decreases in cell density on RGD and RGD+KPSS surfaces, 
though these changes were not significant (p > 0.05). After blocking with soluble heparin, the 
cells that remained attached to KRSR and KRSR+KPSS substrates were noticeably smaller and 
rounder in appearance and their average spread cell areas decreased from 1800 and 1500 µm2 
respectively, to 1000 and 900 µm2 respectively. This trend was reversed on RGD and 
RGD+KPSS substrates, on which the average spread cell areas increased from 1300 and 1200 
µm2 respectively to 1900 and 1500 µm2 respectively after pre-incubating with soluble heparin 
(Figure 5.7a, 5.7b). This result agrees with previous studies that cellular attachment to the 
fibronectin type III domain (FNIII, which contains the RGD motif) is mediated partially by cell 
surface proteoglycans. For example, Dalton et al. showed that the heparin-binding region of 
fibronectin interacts with cell-membrane proteoglycans to promote initial adhesion[226] while 
McCarthy et al. demonstrated that this same heparin-binding region alone could support 
adhesion and spreading of melanoma cells[227]. In our case, we see a positive effect where 
heparin pre-incubation with melanoma cells seems to facilitate spreading to RGD-containing 
peptide substrates, whereas it reduces binding to KRSR-containing substrates. This suggests 
that KRSR peptide and heparin directly competes for binding to cell-surface proteoglycans. In 
fact, if we pre-incubate the peptide substrate with soluble heparin, rather than the cells, we see 
slightly increased cell density on all peptide surfaces (Figure 5.8). 
KPSSAPTQLN promotes melanoma stem cell marker expression 
The KPSS peptide was first reported by Chen and Webster as a bioactive peptide derived from 
the knuckle epitope of BMP7 that could promote osteoblast adhesion, proliferation, alkaline 
phosphatase production, and calcium deposition[44]. We observed that this peptide, when 
immobilized onto a SAM by itself, failed to promote any adhesion of B16 cells (data not shown). 
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However, using this peptide combined with either RGD or KRSR does not impact cell adhesion 
or spreading (Figure 5.7a, 5.9). We prepared SAM substrates bearing RGD and KRSR as single 
peptides and combined with the KPSS peptide, and cultured B16 F0 cells on the substrates for 
1, 3 or 5 days, after which we fixed and stained the substrates for ABCB5 and CD271. We 
observed that over the first 3 days of culture, all peptide conditions appear to have similar cell 
densities and low expression of ABCB5 and CD271. After 5 days in culture however, the 
KRSR+KPSS peptide substrates display significantly higher expression of both ABCB5 and 
CD271 (Figure 5.9b, 5.9c) that correlate well with immunofluorescence data from the peptide 
array (Figure 5.5a) as well as flow cytometry (Figure 5.5c). Since KPSS is derived from BMP7, 
we investigated whether this peptide promotes signaling through BMP receptors. We performed 
western blot analysis of the three main BMP receptors: BMPRIA/ALK3, BMPRIB/ALK6, and 
BMPRII[228] for B16F0 melanoma cells cultured for 5 days on our peptide substrates. For cells 
grown on KRSR+KPSS substrates, we see slightly higher expression of BMPRIA and 
significantly lower expression of BMPRIB compared to RGD. There were no significant changes 
to expression of BMPRII across all peptides (Figure 5.10a). Interestingly there appears to be a 
trend where adding KPSS in conjunction with an adhesion promoting peptide increases 
BMPRIA expression and decreases BMPRIB expression. However, this trend was only 
significant for BMPRIB. Downstream of BMP receptors, the canonical signaling pathway 
involves phosphorylation of Smads 1/5/8[229].  We performed westerns of phosphorylated and 
unphosphorylated Smads 1/5/8, and found no significant changes across the peptide surfaces 
when we compare the ratio of pSmad 1/5/8 to non-phospho Smad 1/5/8 (Figure 5.10a). We also 
performed westerns of phospho- and non-phospho Smad 2/3. Interestingly, when we quantify 
the ratio of pSmad 2/3 to non-phospho Smad 2/3, we see increased Smad 2/3 signaling when 
the KPSS peptide is combined with a corresponding adhesion peptide (Figure 5.10a). This 
effect is most significant when KRSR is combined with KPSS (p<0.01). Typically Smad 2/3 
signaling is associated with TGF-β and activin receptor signaling,[230] though BMPs have been 
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shown to interact with TGFβ receptor type I to activate phosphorylation of Smad 2/3[231]. 
Cassar et al. showed that BMP7 could induce Smad3 phosphorylation in breast cancer cells, 
leading to cell senescence[232], and Holtzhausen et al. recently reported that BMPs could 
induce Smad2/3 signaling, a process that preferentially occurs in cancer and embryonic cell 
lines. They suggest that development provides a non-permissive environment for this mode of 
signaling, while in a more dedifferentiated phenotype, this type of signaling is activated[233]. In 
our system, we see evidence of Smad 2/3 signaling via a BMP7 derived peptide that also 
happens to increase the expression of stem and cancer stem cell markers. 
MAPK activity in response to peptide engagement  
BMP receptors are a subset of the TGFβ superfamily of receptors and have been shown to 
have crosstalk with various other signaling pathways, particularly the MAP kinase 
pathways[234]. We used pharmacological inhibitors of ERK, JNK, and p38 MAP kinase and 
cultured B16 F0 cells on peptide substrates for 5 days, before fixing and performing flow 
cytometry. With ERK inhibition, we see a slight decrease in ABCB5 expression but no change in 
CD271 of our melanoma cell population. With JNK inhibition we see a slight decrease in CD271 
expression but no change in ABCB5 expression (Figure 5.10b). Unlike our previous report using 
patterned substrates which found the p38 MAP kinase pathway as key to regulating cancer 
stem cells[224], we see no change in both ABCB5 and CD271 when using a p38 inhibitor. 
Regulation of cancer stem cell phenotype by patterning and by surface chemistry appears to 
operate via different mechanisms. Interestingly, when we culture the B16 melanoma cells with 
LDN-193189, an inhibitor of BMP type I receptors[235], we see an increase in ABCB5 and 
CD271 expression on both KRSR surfaces (data not shown) and on KRSR+KPSS surfaces 
(Figure 5.10b). This molecule targets BMPRIA and BMPRIB and inhibits phosphorylation of 
Smad 1/5/8[235]. However, we observe that knocking down Smad 1/5/8 signaling increases the 
expression of CSC markers ABCB5 and CD271, further pointing to the role of Smad2/3 and 
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MAP Kinase signaling in promoting a CSC phenotype for the KRSR+KPSS peptide combination 
(Figure 5.10c). 
Metastatic potential and tumorigenicity  
To assess the tumorigenicity of melanoma cells cultured on the various peptide substrates in 
vitro, we performed wound healing and Boyden chamber invasion assays. For the wound 
healing assay, cells cultured on non-patterned peptide SAMs for 5 days were trypsinized and re-
seeded at a concentration of 1 million cells/mL onto glass coverslips to form a confluent 
monolayer. Three scratches were made onto each coverslip, and images of the initial scratch 
and scratch after 12 hours were taken. To quantitatively assess migration, we subtracted the 
final scratch area from the initial scratch area. We observed the highest relative migration from 
melanoma cells cultured on KRSR+KPSS peptide substrates (Figure 5.11a). For the Boyden 
chamber invasion assay, we measured the ability of cells to invade through an artificial 
basement membrane. The migrated cells mostly formed colonies rather than remain single cells 
so we quantified invasion by the nuclear area of the invaded colonies. Similar to the scratch 
migration assay, the cells previously cultured on KRSR+KPSS substrates displayed the highest 
level of invasion (Figure 5.11b). 
We performed in vivo tests for tumorigencity by culturing B16F0 cells on peptide SAM 
substrates for 5 days, followed by trypsinization and resuspension in HBSS buffer. Melanoma 
cells were injected into 6-8 week-old C57BL/6 mice subcutaneously and tumor growth was 
monitored twice per week with calipers. Mice injected with 104 cells quickly developed tumors 
and the mice in the experimental group were sacrificed after 3 weeks due to the large tumors in 
all mice groups at this time. After 3 weeks, the largest tumors occurred on mice injected with 
B16s previously cultured on KPSS-containing substrates, with the KRSR+KPSS condition group 
having the largest tumors (Figure 5.11c). However, at 103 and 102 cells this trend was less 
evident, with only a few mice developing tumors in the low injection number conditions (Figure 
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5.12a). We also assessed metastatic potency with a separate experiment in which we injected 
melanoma cells previously cultured on the four peptide combinations via tail vein injection into 
C57BL/6 mice. However, there was no difference in survival rate after 3 weeks between all the 
peptide conditions (Figure 5.12b). We tested cell viability to see if cells cultured on a particular 
peptide substrate was more prone to anoikis than others. We found no significant changes 
between the peptide surfaces, and >95% initial viability for all conditions. Even after suspension 
in HBSS buffer for 3 hours (experimental injection condition), we see high cell viability for cells 
on all peptide surfaces (Figure 5.13).  
Next, we explored the degree of plasticity of our peptide-cultured melanoma cells, and the 
propensity for reversion to a differentiated phenotype. We cultured B16 F0 cells for 5 days on 
either tissue culture plastic (TCP) or KRSR+KPSS SAM substrates and observed higher ABCB5 
and CD271 expression on cells cultured on KRSR+KPSS substrates (Figure 6). Cells from 
KRSR+KPSS were trypsinized and re-seeded back onto TCP, while cells from TCP were 
trypsinized and re-seeded onto new KRSR+KPSS substrates. The cells were allowed to culture 
for an additional 5 days, after which they were fixed and stained. For the cells that had 
previously been cultured on KRSR+KPSS and re-seeded onto TCP, we see a complete shift in 
ABCB5 and CD271 to the levels of cells cultured initially for 5 days on TCP. Meanwhile, cells 
that had been cultured on TCP and then re-seeded on KRSR+KPSS had the expected high 
expression of ABCB5 and CD271 (Figure 5.14). These results suggest that constitutive binding 
to the KRSR+KPSS peptides are require to maintain a cancer stem cell phenotype. We cultured 
B16F0 cells on KRSR+KPSS substrates for 5 days and monitored ABCB5 and CD271 
expression after removal for an additional 5 days. We see only small changes in expression 
levels after 1 day, but almost a complete reversal after 2 days. This reversal after 2 days likely 
explains why we see evidence of increased tumorigenicity in in vitro scratch and wound assays 
in which the cells are only removed from the KRSR+KPSS substrates for less than 24 hours. 
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However, for in vivo experiments, partial or full reversion of a cancer stem cell phenotype may 
occur during the weeks-long time required to see changes in tumor growth. Together, these 
results demonstrate that melanoma cells are highly plastic, and that their phenotype can be 
regulated by biophysical cues. By investigating various peptide-presenting SAMs, we identify a 
unique combination which upregulates many putative stem and cancer stem cell markers. Our 
results highlight the importance of heparin and proteoglycan-mediated adhesion, which when 
combined with a BMP7 morphogen, promotes non-cannonical Smad 2/3 signaling to upregulate 
a tumorigenic CSC phenotype (Figure 5.10c).     
5.4.  Conclusion 
Our results demonstrate the utility of a peptide microarray for screening specific cell-ligand 
interactions. Microarray platforms typically profile adhesion patterns, though we report that they 
can also identify synergistic bioactive activities. Although this study only investigated a 5-day 
time point, we have been able to generate cell arrays lasting up to two weeks by tuning seeding 
concentration and culture conditions. One could thus use a similar strategy to investigate the 
effects of ECM on a broad range of biological properties. 
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5.5 Tables and Figures 
 
 
 
 
Figure 5.1 Schematic for generating peptide microarrays. An OmniGrid microarray spotter deposits nanoliters of 
a spotting solution containing EG3-terminating alkanethiols, and peptide-terminating alkanethiols onto a gold 
surface. A background EG3-terminating alkanethiol passivates the non-spotted regions, and seeded cells adhere 
only to peptide-terminated regions of the self-assembled monolayer (a). Representative image showing B16 F0 
melanoma cells adhering to the array (b) and a representative subarray (insert). Scale bar is 500µm and 200µm 
for insert. 
 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Adhesion profile of B16 F0 cells on replicate array surfaces. The highlighted diagonal represent single 
peptides. 1 = GRGDS, 2 = YIGSR, 3 = IKVAV, 4 = FYFDLR, 5 = KRSR, 6 = FHRRIKA, 7 = SHWSPWSS, 8 = 
DWIVA, 9 = KPSSAPTQLN, 10 = YSDKSLPHP, 11 = HYQASVSPEPP, 12 = IPKVELVPAG 
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Figure 5.3 To quantify marker expression, a region of interest (ROI) is drawn around each array spot (a). For cell 
counting, the DAPI channel is used (b)and the number of cells in each ROI is quantified (c). For quantifying 
antibody markers, a threshold is used to select positive marker expression (d,e). The overall intensity score for 
each ROI is equal to the integrated density of marker expression divided by the area of all nuclei. 
 
Figure 5.4 Cell density affects the automated counting in ImageJ. For highly confluent spots, the segmented 
count tends to undercount the total number of cells due to the software being unable to segment nuclei in close 
proximity. By counting cells based on measuring the total area of DAPI stains and dividing by the average size of 
each nuclei, we obtain similar values as manual counting. 
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Figure 5.5 Representative images of a panel of putative melanoma cancer stem cell markers and markers 
associated with cancer stem cell phenotypes (a). A high correlation was found between CSC markers ABCB5 and 
CD271. Over three experimental repeats, the peptide combination KRSR+KPSS consistently showed high 
expression of both markers on the array (b). Non-patterned peptide substrates for RGD, RGD+KPSS, KRSR, and 
KRSR+KPSS were used to culture large numbers of B16 F0 cells for flow cytometry analysis. Flow cytometry 
confirms that cells cultured on KRSR+KPSS substrates display higher levels of ABCB5, CD271, Jarid1b, and 
Stat3. 
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Figure 5.6 Marker intensity scores plotted ABCB5 and CD271.   
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Figure 5.7 Actin staining of B16 F0 cells on non-patterned peptide SAMs with and without pre-incubation with 
soluble heparin (a). Quantification of cell density (cells/cm2) and cell spread area (µm2) on these surfaces (b). 
Scale bar = 500µm. Error bars represent ± S.E.M. * P < .05, ** P < .01, based on one-way ANOVA with Tukey 
HSD post hoc testing. 
 
Figure 5.8 Cell density of B16 F0s when the peptide substrate is pre-incubated with or without soluble heparin.   
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Figure 5.9 Cell density (a) and ABCB5 (b) and CD271 (c) intensity (arbitrary units) of B16 F0s cultured on non-
patterned peptide SAMs. Cells were fixed and analyzed at 1 day, 3 day, and 5 day time points. Error bars 
represent ± S.E.M. * P < .05, ** P < .01, based on one-way ANOVA with Tukey HSD post hoc testing.   
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Figure 5.10 Western blots for BMP receptors and Smad proteins (a). BMPR quantification was normalized to 
GAPDH. Smad signaling was normalized by phosphorylated Smad against non-phosphorylated Smad. Flow 
cytometry histograms for B16 F0 cells cultured for 5 days on non-patterned peptide SAMs in the presence of 
pharmacological inhibitors for ERK, JNK, P38, and LDN-193189, an inhibitor of BMP type I receptors (b). 
Proposed pathway for peptide mediated signaling guiding CSC phenotype (c). Error bars represent ± S.E.M. * P < 
.05, ** P < .01, based on one-way ANOVA with Tukey HSD post hoc testing. 
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Figure 5.11 Wound healing and Boyden chamber invasion assay for B16F0 cells cultured on non-patterned 
peptide substrates for 5 days. Wound healing scratches were imaged immediately and 12 hours after initial 
scratch time to quantify relative migration (a). Relative invasion was quantified by measuring the total area of all 
cell nuclei that invade through the basement membrane 12 hours after seeding (b). Average tumor volume (mm2) 
in C57BL/6 mice that developed tumors after subcutaneous injection of B16F0 cells that had been cultured on 
non-patterned peptide SAMs for 5 days (c). Scale bar = 200µm. Error bars represent ± S.E.M. * P < .05, ** P < 
.01, based on one-way ANOVA with Tukey HSD post hoc testing. 
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Figure 5.12 Tumorigenicity results (number of mice that develop tumors) after limited dilution of B16F0 cells from 
non-patterned peptide SAMs (a). Survival rate of C57BL/6 mice after tail vein injection (30,000 cells) of B16F0 
cells cultured on non-patterned peptide SAMs (b).   
Figure 5.13 Cell viability as assessed with annexin V and propidium iodide staining via flow cytometry. Cell 
viability was measured initially as cells were trypsinized and removed from non-patterned peptide SAMs, and 
after 3 hours suspension in HBSS buffer.    
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Figure 5.14 B16F0 cells were cultured for 5 days on either tissue culture plastic (TCP), or KRSR+KPSS non-
patterned SAM substrates. After 5 days of culture, cells were fixed for flow cytometry analysis, though 10,000 
cells from each condition were re-seeded onto either KRSR+KPSS (initially cultured on TCP), or onto TCP 
(initially cultured on KRSR+KPSS). After an additional 5 days of culture, these cells were fixed for flow cytometry 
analysis. 
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Table 5.1 Biomimetic peptides and derived sources 
# Sequence Source 
1 GRGDS[165] Fibronectin, Vitronectin 
2 YIGSR[213] Laminin 
3 IKVAV[214] Laminin 
4 FYFDLR[215] Collagen IV 
5 KRSR[178] Laminin 
6 FHRRIKA[190] Bone Sialoprotein 
7 SHWSPWSS[216] hThrombospondin 
8 DWIVA[217] BMP-2 
9 KPSSAPTQLN[44] BMP-7 
10 YSDKSLPHP JAGGED-2 
11 HYQASVSPEPP DELTA-1 
12 IPKVELVPAG ACTIVIN-1 
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CHAPTER 6 
APPLICATIONS AND FUTURE DIRECTIONS5 
6.1 Summary 
The concept that stem cell behavior in vivo is controlled by a natural “niche” has motivated the 
design and creation of synthetic materials to mimic the behavior of this stem cell niche 
environment.  Stem cell niche environments include multiple signals that can drive the cells to 
proliferate, self-renew, or differentiate.  Often these signals are conserved, and cross-talk 
between signaling pathways serve to complicate the identification of the roles of specific 
pathways[236].  The natural niche is fluid and dynamic, and one of the ways cells can “feel” their 
environment is through traction forces exerted by the cell with the surrounding matrix.  These 
forces lead to changes in cell shape and intracellular cytoskeletal tension, and ultimately can 
influence gene expression[237]. While the precise mechanics involved in how biological signals 
are induced by material properties is not fully yet understood, at the core is the link between the 
cell cytoskeleton and the material[238].  Environmental cues such as stiffness and topography, 
and changes in adhesion ligands or restriction of cell size, all affect the contractility of actin and 
its motor myosin II, to direct cells toward specific processes. 
Within this thesis, we have examined some of these environmental cues and investigated their 
effects on cellular processes. We began in chapter 2 by looking at the role of cell shape and 
studying how by constricting cell shape, we can promote a more naiive phenotype in 
mesenchymal stem cells. In chapter 3 we introduced a new technique that could tune both 
shape and surface ligand. By doing so we were able to study how shape and ligand interactions 
can have synergystic or antagonistic effects on promoting differentiation of MSCs into a smooth 
 
5Parts of this chapter has been adapted from the following publication:   
Joshua M. Grolman, Douglas Zhang, Andrew M. Smith, Jeffrey S. Moore, and Kristopher A. Kilian, Rapid 3D extrusion of synthetic 
tumor microenvironments, Advanced Materials, 2015, 27 (37), 5512-5517. 
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muscle phenotype. Although we saw differences based on ligand affinity, the traditional micro-
contact printing approach we used in chapters 2 and 3 is relatively low throughput and only 
allows the study of a small combination of surface ligands. To resolve that challenge, we 
developed an array platform in chapter 4 that is capable of spotting any combination of 
peptide(s) in a high-throughput fashion to allow systematic investigation of cell-material 
interactions. Chapter 4 served as a proof of concept that this array platform is robust and can 
differentially detect phenotypic changes in cultured cells. In chapter 5, we demonstrated that 
control of material properties to direct stem cell fate has benefits not only in stem cell and tissue 
engineering, but cancer therapy as well. Recent advances into the pathogenesis of melanoma 
metastasis has revealed that a small subpopulation of tumor-initiating cells, postulated to be 
cancer stem cells, correlate with metastatic progression[193].  Like traditional stem cells, these 
CSCs are thought to be highly proliferative, self-renew, and have the capabilities of 
reconstituting the entire tumor environment[194].  The cancer stem cell hypothesis helps explain 
the perplexing and poorly understood clinical phenomena where a patient with cancer may have 
robust response to chemotherapy treatment only to have eventual relapse[195].  We used our 
peptide array platform to investigate CSC markers and identified a microenvironment that 
affects the phenotype of melanoma cells and makes them more invasive. Additional studies 
focused on identifying CSCs could provide new insights into the pathology of tumor metastasis, 
and the existence of CSCs offers potentially new therapeutic strategies targeting these specific 
cells. 
6.2 Future directions 
Numerous studies in the field of biomaterials have demonstrated the importance of substrate 
elasticity on the proliferation, expansion, and differentiation of both stem cells and cancer 
cells[201,238].  Although SAMs on gold provide well defined surfaces to study ligand interaction, 
substrates that approximate the mechanical properties of soft tissues have been shown to be 
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more predictive of in vivo outcomes[123].  Therefore, a hydrogel-based platform in which we 
can tune both the substrate stiffness as well as the peptide ligand combination may be more 
instructive for predicting cancer progression.  Development of a tunable hydrogel with sufficient 
azido-functional groups on the surface will allow translation of our current peptide array to a gel-
based system.  We currently have a tunable polyacrylamide gel system in which acrylamide and 
bis-acrylamide monomers can be mixed in varying ratios to change the stiffness of the gel.  
Hydrazine hydrate is then used to convert the amide groups in polyacrylamide to reactive 
hydrazide groups.  Preliminary experiments have demonstrated that we can adequately 
functionalize proteins with free aldehydes onto these gels using the OmniGrid arrayer (Figure 
6.1).  Similarly, we can incorporate an aldehyde linker onto our library of peptides and adapt the 
current gold-based spotting strategy to a gel-based platform. However, the tunability of the gel 
system will allow us to examine differences in cancer stem cell marker expression within a 
range of mechanical stiffness, a parameter that has already been shown to be important in 
tumor progression models.  
A recent report by Lee et al. showed that melanoma CSC phenotype can be modulated by 
interfacial geometry and subcellular tension[224]. Their reported mechanism on how these cells 
undergo EMT into a more invasive phenotype appears distinct from the one we discovered in 
chapter 5. Our peptide patterning technique from chapter 3 presents an attractive platform by 
which to investigate the combinatorial role of ligand and interfacial geometry (Figure 6.2). By 
using the microarray to identify “hits” of peptide combinations that enhance tumorigenicity, we 
can perform additional studies using some of the shapes designed by Lee et al. to understand 
how CSCs retain their invasive phenotype. By combining ligand and geometry, we will be able 
to gain a greater understanding of how these complex dynamics interplay. 
An additional application of the microarray platform is the identification of clinically relevant 
peptides for incorporation into next generation 3D hydrogels. Compared to traditional 2D culture 
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in a petri dish, 3D culture allows more accurate replication of natural tissue and matrix 
organization[61,239,240]. In vitro models developed for drug screening have demonstrated 
differences in cell proliferation, morphology, and drug response for 3D compared to 2D 
systems[241,242]. The need for 3D culture systems is especially apparent in the field of drug 
screening. Solid tumors house an assortment of complex and dynamically changing 
microenvironments in which signaling events between multiple cell types are known to play a 
critical role in tumor progression, invasion, and metastasis. To deepen our understanding of this 
biology, it is desirable to accurately model these structures in vitro. However, current systems 
fall short of mimicking the complex organization of cells and matrix in vivo. We have already 
developed a technique to make high-throughput co-cultured alginate fibers in a single step. We 
previously investigated human breast adenocarcinoma cells and mouse macrophage cells and 
showed that our system allowed us to screen pharmacological inhibitors for their ability to 
disrupt the macrophage-tumor cell paracrine loop (Figure 6.3)[243]. In that study, we used a 
common ECM adhesive peptide to allow the macrophages and tumor cells to adhere to the 
alginate matrix. However, future studies could readily incorporate hits identified from the peptide 
microarray. By doing so, we could generate synthetic 3D microenvironments that promote an 
invasive phenotype, and use patient-derived cells to more accurately screen anti-cancer drugs.  
Drug discovery and development is both expensive and time consuming, with average time from 
laboratory concept to FDA approval exceeding 10 years, and average expenditure in excess of 
$1 billion[244]. The current standard for anti-cancer drug development relies on standard 2D 
culture conditions with established cell lines, followed by xenotransplantation assays in 
immunocompromised mice to determine drug candidate efficacy. Although mouse models have 
been known to have poor predictive capabilities for clinical outcomes[245], they remain the 
standard due to lack of robust alternatives. These pre-clinical models have poor predicitive 
powers due to differences of in vitro culture conditions compared to the complexity of a natural 
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tumor microenvironment, as well as differences between human and mice biology. Many 
compounds which advance to the late phase II/III clinical studies end up failing for these 
reasons[246], highlighting to importance of developing new robust cancer models capable of 
recapitulating native tumor complexity. Within the chapters of this dissertation, we are able to 
contribute our own findings and identify key techniques that will prove useful in advancing our 
current in vitro models of cancer. We highlight a peptide microarray technique that can 
reproducibly screen large experimental spaces of ligands and identify conditions that contribute 
towards a metastatic phenotype. The advantage of our technique is that it is not simply limited 
to peptides and can be adapted to array any alkyne-containing molecule. More importantly, the 
use of small bioactive ligands allows easy scale-up and translation to a wide range of 
biomaterials. We present one such application of a 3D tumor model within this chapter (Figure 
6.3). Further research into identifying ligands that can mimic the in vivo tumor microenvironment 
will only improve the biological and physiological relevance of next-generation in vitro cancer 
models[247]. We propose that materials platforms such as our peptide microarray serve not 
only as tools for explorary research, but are necessary in advancing progress towards truly 
personalized cancer treatments. 
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6.3 Figures 
 
 
BF 
DAPI 
ABCB5 
CD271 
Figure 6.1 Mesenchymal stem cells cultured on an array of fibronectin-containing spots on a 40kPa 
polyacrylamide gel. 
Figure 6.2 B16F0 cells are cultured on a peptide self-assembled monolayer patterned into a flower shape. This 
strategy allows simultaneous investigation of both ligand as well as interfacial geometry effects on promoting a 
cancer stem cell phenotype. 
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Figure 6.3 Straight and patterned hollow alginate structures can be extruded using a simple microfluidic 
technique (left). These alginate backbones are peptide-conjugated to allow for cell attachment and culture. We 
can use such a structure to model the interaction between cancer cells and healthy cells (middle). By labeling the 
individual cells, we can track how they migrate within the 3D microenvironment. One application of this technique 
is for drug screening (right). Green = macrophages, Red = cancer cells. 
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